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1. Introduction
Gut flora
The total of all microorganisms residing in our gastro-intestinal tract is called the gut 
flora. In the last years many studies have shown the significance of this flora for 
humans. There are 10-100 times more bacteria residing in our intestine than the total 
number of cells in our body. 1014 bacteria out of more than 1000 species, and thereof at 
least 160 species per individual, are colonizing our intestine [1]. Out of the 70 known 
phyla, only 7 are found in human intestine until now and therefrom Firmicutes and 
Bacteroides constitute 90% [2]. In addition there are eukaryotes, archaea and viruses. 
The composition of bacterial species differs from individual to individual and is 
dependent on many different factors. The most important are ethnicity, geography, 
genetics and later on age and diet. Furthermore in present times there are also factors 
like antibacterial treatment,  hygiene and lifestyle which can influence and disturb the 
natural balance of gut microflora. 
Humans are born with a sterile intestine. The first essential influence on the constitution 
of our intestinal microbiota is the way of delivery (vaginal versus caesarian) [3][4], 
followed by the infant's nutrition, meaning over all whether the mother is breastfeeding 
or not [4]. Probably the most important part for the development towards an individual 
microbiota is done in the first years of living and this is the time where it is the most 
influenceable. 
Bacteria in our intestine have to deal with concurrence between different species, 
intestinal peristaltic and the human immune system. They adapt to these factors in a 
permanent dynamic. This is how a balance is created between those bacteria which 
establish themselves and constitute our gut microbiota. They develop adhesion systems 
to avoid being purged out by intestinal peristaltic [5]. Between the human immune 
system and the bacterial antigens a permanent exchange is happening. It has been shown 
that Bacteroides living in intestine make a DNA-transfer with their environment. In this 
way they make themselves a unique line ideally adapted to each host [6]. 
The symbiosis allowing the survival of gut bacteria has an important benefit for 
humans:
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The major beneficial functions of intestinal bacteria are the metabolism of 
otherwise indigestible polysaccharides such as cellulose and some starches [7], the 
production of  a high part of short chain fatty acids which are very important for the 
intestinal mucosa [8], the production of vitamin K and certain amino acids [9] and a 
protective effect on the intestinal mucosa [10]. 
The intestinal microbiota with its direct influence on intestine, digestions, energy 
balance and immune system has also an impact on our whole body. Early studies on the 
intestinal microbtiota have shown correlation between certain bacterial species and 
overweight: The ratio Bacteroides/Firmicutes is reduced in overweight individuals 
[11][12] and bacteria such as Lactobacillus are found to be increased [13]. Furthermore 
there was a report suggesting a link between a certain composition of intestinal 
microbiota and inflammatory bowel disease  [14], irritable bowel syndrome and 
colorectal carcinoma [15]. 
The intestinal bacteria can also influence many extra intestinal organs. For example a 
link is hypothesized between intestinal microbiota and diabetes [16], allergies [17] and 
lymphomas [18]. Even on behavior, psyche, memory, learning, depression, cognition 
and pain the intestinal flora seems to have an impact  [19][20]. 
How can this influence on health by gut bacteria be explained?
As mentioned above, there is a permanent exchange between gut flora and immune 
system. The consequence is finally a toleration of symbiotic bacteria on one side and a 
regulation – in some cases a deregulation- of the immune system on the other side. And 
this is probably where the most important interaction between bacteria and other body 
systems is made. The detailed mechanisms of these interactions are not yet completely 
understood but there are already many approaches: 
Intestinal bacteria are foreign organisms to our body and possess antigens which are 
recognized from our dendritic cells. Conditioning of the dendritic cells in our intestinal 
mucosa occurs by intestinal bacteria [21]. Then dendritic cells present the antigens to T-
cells in spleen and lymph nodes, which stimulate differentiation of leukocytes in the 
bone marrow. Pathogen-associated microbial pattern (PAMPs) and differentiation of the 
immune system is stimulated [22]. 
To avoid their elimination by local immune reaction, intestinal bacteria develop 
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mechanisms like inhibition of the immune regulating transcription factor Nf-kB [23], 
tolerance against endotoxins [24] or production of metabolites that take influence on the 
immune system. Short-chain fatty acids are produced by bacteria such as Roseburia, 
Eubacterium, Bacteroides, und Faecalibacterium and have an anti-inflammatory effect 
by inducing differentiation of regulatory T-cells (Treg-cells), which play an important 
role in autoimmune diseases by suppressing immune system to enable self-tolerance 
[25]. In intestine and CNS, Treg-cells prevent inflammation through IL-10 [26]. 
Polysaccharide A and niacin produced by certain intestinal bacteria also trigger Treg-
cells [26][27]. Intestinal bacteria also play a role in the metabolism of arachidonic acid 
into leukotrienes and prostaglandins. These two products are signaling molecules of 
inflammation processes in our body. Bacteroides thetaiotaomicron for example is a 
bacterium of the intestinal flora which increases the level of prostaglandin in mice [28]. 
In general most of these processes are observed in mice. This does not always allow 
inference on human beings. Nevertheless these exemplary listed mechanisms give us a 
view into the effect of intestinal microbiota on our immune system and thereby 
connected diseases. 
The functional association between gut and CNS is well known: With the N. 
vagus digestion is controlled and gut sensations are carried to the CNS. Through 
ghrelin, neuropeptide Y, peptide YY and cholecystokinin the intestine gives information 
about hunger and satiety to the CNS [29]. Interestingly messenger molecules can be 
influenced by the intestinal microbiota [32].
Enterochromaffin cells of the intestinal mucosa synthesize a  large part of serotonin 
available in our body [30]. Serotonin does not only regulate digestion but is also 
responsible for multiple processes in other systems such as mood, behavior and psyche 
[31]. Production of serotonin and dopamine can be directly stimulated or made by 
bacteria [22]. Furthermore neuropeptides can be neutralized by antibodies. And this 
process can be influenced by bacteria with certain antigens, which increase the 
production of these antibodies by molecular mimicry [33]. 
Antibodies against neuropeptides stimulating hunger also seem to play a role in 
anorexia nervosa [33]-[36]. 
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Anorexia nervosa
Anorexia nervosa will be described in detail in this chapter because the presented 
research project was made on a stool sample collected from an anorexic patient. 
Anorexia nervosa  is an eating disorder. Affected patients induce a loss of weight by 
very restrictive food intake and active measures such as use of laxatives, vomiting or 
extreme physical activity. Their body weight is at least 15% lower than normal weight. 
This disease is getting more important and has overall lifetime prevalence of 0,6% and 
the prevalence in women is 0,9% [37]. Comorbidity of this eating disorder is high 
because of underweight [38]. Mortality is around 10% and so the highest under 
psychological diseases [39]. 
In 1996 already it was hypothesized that certain neuropeptides are jointly responsible 
for the genesis of anorexia nervosa [40]. Later a correlation between antibodies against 
α-MSH and anorexia nervosa  has been reported [35], respectively especially to the 
psychological characters of this disease like social insecurity, interpersonal distrust, 
impulse regulation and asceticism [36]. The fact that intestinal microbtiota can influence 
the production of  antibodies by molecular mimicry, has finally proved in a study by 
Fetissov et al. [33]. It has to be mentioned that probably in all humans, neuropeptides 
with influence on food intake and emotions are physiologically regulated by antibodies 
[34]. But Ghrelin, an appetite stimulating hormone, is interestingly found in a higher 
level in free form in plasma of anorexic patients, because there are less antibodies 
against this hormone than in healthy subjects [41]. A reduced feeling of hunger in 
anorexia patients could be explained through a resistance against Ghrelin developed by 
this phenomena. 
Supposedly the intestinal microbiota is influenced by the very restrictive food intake. A 
study showed that Methanobrevibacter smithii was found increased in the intestine of 
anorexia patients compared to healthy subjects [13]. M. smithii is able to metabolize H2 
and CO2 to methane, which improves the bacterial metabolism and therefore the energy 
balance [42]. 
Apart from these discoveries there is not much known about special characteristics of 
anorexia nervosa patients' intestinal microflora. The above described effect of 
antibodies against neuropeptides has indeed been assigned to certain bacterial 
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populations [33], but we don't know yet if these are reduced or increased in anorexia 
nervosa patients. 
However several metagenomic studies on the microbiome of undernourished children 
have been published [43]–[46]. Correlations between certain bacterial groups and 
children's weight have been found in all of these studies: Transplantation of intestinal 
microbiota of a undernourished child into germ-free mice resulted in a loss of weight 
for these mice [45]. On the other hand the microbiome of undernourished children could 
be changed by the intake of Ready-to-Use Therapeutic Food (RUTF) [45]. This is a 
proof that body weight is influenced by gut flora on one side and that the gut flora is 
dependent on diet on the other side. Protective bacteria for the intestinal mucosa which 
do either produce short-chain fatty acids such as  Butyrivibrio, or do have anti-
inflammatory effects such as Eubacterium and Faecalibacterium, were missing in 
undernourished children in India [43]. Bacteroides, which induce a loss of weight in 
overweight individuals, were increased in undernourished children [44] and were 
reduced after intake of RUTF in an other study [45], which let us suppose a very direct 
adaption of microbiome to diet. Lactobacilli and Bifidobacteria levels were increased 
after intake of RUTF [45]. These bacteria seem to have a positive effect concerning 
inflammation and pathogenic bacteria in human intestine. Pathogenic bacteria as well as 
bacteria linked to inflammatory bowel disease or irritable bowel syndrome in other 
studies, have been found in undernourished children's intestine [45][44]. Once the 
microbiome is altered due to undernourishment it is influencing energy balance and 
health negatively. In consequence there is a hope to find an other therapeutic approach 
apart food intake for malnutrition by using certain bacterial groups.
In general, considering these links between gut flora and organism found until 
now, one can suggest that a part of our modern civilization diseases can be explained by 
the altered constitution of our intestinal microbiota. A disturbed balance is resulting in a 
reduction of diversity, because different bacterial lines can not live next to each other 
anymore. But it is especially the large diversity which is important for human beings. 
Pathomechanisms, through which intestinal bacteria influence health and behavior, as 
well as resulting therapeutic approaches are currently intensively researched. 
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Metagenomics versus Culture and the field of unknown 
bacteria
A big progress has been made in the last twenty years in the field of metagenomics. 
With this new technique the step of culturing can be skipped and samples can be 
examined directly on the contained genes. In a relatively short time a very large view on 
the complete genes of all in this sample living microorganisms can be obtained – and 
depending on the technique either about metabolic functions of the microsystem, either 
about the contained species. Cultivation seemed to be unnecessary for several years. 
But in metagenomics also there are gaps. First, bacteria contained in a very low 
concentration are hardly captured by metagenomics [47]. Secondly, one study of the 
laboratory in which the present research has been made, showed that from the same 16 
samples metagenomics and gram-straining obtained discrepant results and that with 
metagenomics an important part of gram-negative bacteria could not be captured [48]. 
Next to broad metagnomic studies, cultivation seems therefore to stay an essential 
element in research in the aim to obtain an as complete image as possible of the 
examined sample, in our case of the gut flora. 
With metagenomics,microbiology gained new insights in the world of bacteria: Less 
than 1% of all existing bacteria could have been cultivated so far [49] and through 
metagenomic studies a large number of bacteria has been identified, which have not 
been isolated by culture until now. There are whole phyla of which no representative 
species could be cultivated [50]. These bacteria are classified as „uncultivable“ and thus 
seem to be accessible by metagenomics only. On one hand this points out the unique 
role of metagenomics. On the other hand those „uncultivable“ bacteria give a new 
challenge to microbiology. Many research projects work to solve this problem by 
developing new culture conditions for those bacteria and have success in this effort 
[51][52]. The description „uncultivable“ is therefore not definitive – it is rather 
visualizing the large unknown field of bacteria. 
Finally, unknown bacteria also bring a challenge to metagenomics. It concerns 
unclassified gene segments, which cannot be assigned to known genes. This can be 
caused by a too short segment and by still existing technical inaccuracy and limits of 
metagenomics. But it can also be possible that these unclassified gene segments do not 
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have a correspondent known segment in the database, can therefore not be classified and 
must belong to yet unknown bacteria. Whether by culture or metagenomics: the biggest 
part of bacteria is still unknown.
This unexplored field is also present in gut microbiota, although it is relatively 
small compared to environment. In human gut flora, 70-90% of the bacteria have not 
been cultivated yet [55] and out of all genes from respective samples more than half 
cannot be assigned. The latter has been deduced of „An integrated catalog of reference 
genes in the human gut microbiome“ [56], in which genes of already published and of 
new studies have been integrated. This makes a pool of more than 1200 samples from 
three continents. The collected examined genes were compared to 3,449 reference-genes 
of bacteria and archaea. Here 21,3% could be assigned only on phylum level and 44,4% 
to a genus or species. In the „Genomes Online Database“ metagenomic and genomic 
results are collected and recapitulated worldwide [57]. All following listed numbers and 
percentages are taken from the internet page on January 12th 2016: 
From all examined ecological systems, samples isolated from humans represent 23%. 
37,4% of these microorganims isolated from human are obtained from the digestive 
system, and it has to be considered that further 37,1% remain unclassified. This shows 
that by far most microorganism in humans have been isolated from the intestine. 
Moreover from no class of organisms as many microorganisms have been isolated as 
from human digestive system. 5,8% of all genomes in the collection GOLD were 
obtained in the Human Microbiome Project. This means that a considerable part of 
unknown bacterias can be isolated from human stool samples. 
This is how within two years 31 new species have been discovered in 4 examined 
human stool samples by cultivation [47]. 
With its large diversity of bacterial species, the gut flora can provide new insights into 
the yet relatively unexplored field of bacteria. To obtain a large view on bacterial 
species living in human intestine, the following project has been initiated by a research 
group of Prof. Raoult in the Research Unit in Infectious and Tropical Emergent 
Diseases, Marseille, France: 
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Culturomics project and aim of this thesis
The project is concentrating on two aspects: the inter-individual and the individual 
diversity of the gut flora. To explore both aspects, stool samples have been collected and 
examined firstly from different continents [47], from humans with and without 
antibiotic treatment  [58], from overweight [47] and normal weight persons, in this work 
from an anorexia patient, and even from a gorilla [59] to get a big variation of 
influencing factors on the constitution of gut flora. Secondly many different culture 
conditions have been applied on each sample with the aim to isolate the most possible 
bacteria from each sample. In parallel, DNA extracted from the samples has been 
amplified on the 16S rRNA-sequence and sequenced to identify on metagenomic level 
the species contained in the stool sample. This approach is made to complement 
metagenomis and culturing with each other, to minimize respective gaps and to obtain 
the most possibly complete view on the microflora from one single individual.
The stool sample I examined as a part of this project was obtained from a 21-
year old french  anorexia nervosa patient. Which bacteria have been identified in this 
stool sample by metagenomics or culturing, in which culturing conditions they were 
isolated, the classification of the identified bacterial species, as well as a comparison of 
the two methods have been published in „Culturomics identified 11 new bacterial 
species from a single anorexie nervosa stool sample”. This publication is following in 
chapter 2.1. Further articles describe the bacteria which have been newly discovered in 
this work. One of these articles is included in this dissertation (chapter 2.2.). Four more 
can be found in NCBI and the six left are in progress. 
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2. Material and methods / results.
2.1. Publication I:
European Journal of Clinical Microbiology and Infectious Diseases 2013 Nov; 
32(11):1471-81. 
doi: 10.1007/s10096-013-1900-2. Epub 2013 Jun 2.
Culturomics identified 11 new bacterial species from a single 
anorexia nervosa stool sample
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ABSTRACT
The rebirth of the bacterial culture has been highlighted successively by 
environmental microbiologists, the design of axenic culture for intracellular bacteria in 
clinical microbiology, and more recently by the human gut microbiota studies. Indeed, 
microbial culturomics (large scale of culture conditions with identification of colonies 
by MALDI-TOF or 16S rRNA) allowed to culture 31 new bacterial species from only 4 
stools samples studied.  
We performed microbial culturomics in comparison with pyrosequencing 
16SrRNA targeting the V6 region, on an anorexia nervosa stool sample because this 
clinical condition has never been explored before by culture while its composition has 
been observed atypical by metagenomic. 
We tested 88 culture conditions generating 12,700 different colonies identifying 
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133 bacterial species with 19 bacterial species never isolated from the human gut 
before, including 11 new bacterial species which genome has been sequenced. These 11 
new bacterial species isolated from a single stool allow to extend more significantly the 
repertoire in comparison to the bacterial species validated by the rest of the world 
during the 2 last years. Pyrosequencing indicated a dramatic discrepancy with the 
culturomics results, with only 23 OTUs assigned to the species level overlapping (17% 
of the culturomics results). Most of the sequences assigned to bacteria only detected by 
pyrosequencing belonged to Ruminococcaceae, Lachnospiraceae and 
Erysipelotrichaceae constituted by strictly anaerobic species, indicating the future route 
for culturomics.
This study revealed new bacterial species participating significantly to the 
extension of the gut microbiota repertoire, first step before to connect the bacterial 
composition with geographic or clinical status. 
INTRODUCTION 
Microbial culture has been neglected in clinical microbiology since few years 
compared to molecular tools [60]. This was particularly relevant for the gut microbiota 
study which is currently only studied by metagenomic and 16S rRNA pyrosequencing, 
abandoning progressively new culture conditions design [61]. This has been generalized 
in microbiology excepted for the fastidious and intracellular bacteria with the 
development of axenic culture [62][63]. Nevertheless, environmental microbiologists 
have continued to develop empirical strategies using respectively diffusion chamber and 
isolation chip allowing to enlarge dramatically the repertoire of cultured 
microorganisms [64]–[66]. Indeed, thanks to the design of new culture conditions and 
the improvement of identification methods, the number of bacterial species increased 
from 1,791 in 1980 to more than 12,000 in 2013 [60], [67]. We have recently used a 
large scale of culture conditions allowing to promote the growth of fastidious species or 
conversely to inhibit the growth of dominant bacterial populations [47]. The 
identification strategy was based on MALDI-TOF followed by 16S rRNA amplification 
and sequencing for the misidentified strains because of previously unknown spectra or 
of new bacterial species (microbial culturomics) [47]. The first culturomics study, 
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testing 32,500 colonies by MALDI-TOF, allowed to identify 340 bacterial species 
including more of half first described from human gut, and 31 new bacterial species 
which genome has been sequenced and a majority of these has been already described 
[68]–[79].  In addition this culture approach has allowed in 2012, 3 world records in 
Microbiology, the largest human bacterial genome (Microvirga massiliensis, 9.3 Mb), 
the largest human virus (Senegalvirus, 372 Kb) and the largest human archaeal genome 
(Methanomassiliicoccus luminyensis, 2.6 Mb) [80], [47].
In order to optimize our chances to recover unknown species, we have previously 
selected atypical human stool samples because of geographic provenance (Senegalese or 
French individuals), or because the patients were treated by large antibiotics regimen 
which changing the microbiota [81], [82]. In the aim to describe new microorganisms 
from human, we propose to continue to apply in different samples microbial 
culturomics, a time-consuming technique because it requires to test at least 10,000 
colonies in each stool samples studied [47][81].
Herein, we propose to study for the first time an anorexia nervosa stool sample by 
culturomics because the gut microbiota composition in these patients, previously 
explored by molecular techniques and appeared atypical [13]. The new bacteria 
cultured, will not necessarily associated to the status of the individuals studied. 
Nevertheless, we propose a pioneer study allowing, foremost, to describe new bacterial 
species. A possible link with clinical condition or geographic provenance could be 
secondarily studied when the repertoire will be more comprehensively completed. 
MATERIALS AND METHODS
Patient stool collection
The analyzed stool sample was obtained from a 21-year-old French Caucasian 
female who had suffered from a severe restrictive form of anorexia nervosa since the 
age of 12. Despite continuous nutritional and psychiatric support, the natural history of 
her disease was characterized by an absence of clinical remission (BMI fluctuating 
between 10 and 15 kg/m2) and a succession of acute episodes inducing life-threatening 
malnutrition and the need for hospitalization in critical care units. At the time of sample 
collection, she was hospitalized in the Nutrition unit of our hospital due to recent 
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aggravation of her medical condition. Her weight was 27.7 kg, and her height was 1.63 
m (BMI: 10.4 kg/m2). The stool sample was collected on her first day of hospitalization, 
before the introduction of tube feeding. The dietary habits of the patient were surveyed 
and were mainly based on vegetables and fruits and milk product.
We collected 97 g of stool from the patient, which we aliquoted into 1 g samples 
and stored at -80°C immediately after collection because a low temperature has been 
reported as the best condition for longtime conservation [83]. The patient’s written 
consent and the agreement of the local ethics committee of the Institut Fédératif de 
Recherche 48 (IFR48) were obtained (agreement number 09-022, Marseille, France). 
Microbial culturomics:
Culture: 
Each gram of stool was diluted in 9 ml of DPBS and inoculated into different 
culture media under variable conditions in a dilution series ranging from 1/10 to 1/1010. 
To isolate bacteria, referring to a preliminary study of the human intestinal microbiota, 
we inoculated stool samples into 88 preselected culture condition treatments, which 
produced a high diversity of isolated bacteria (Table S1). These culture conditions are 
based on multiple different physicochemical conditions, atmospheres, the use of E. coli 
phage, and passive and active filtration, including preincubation in blood culture bottles 
and utilizing rumen fluid and fresh sterile stools, with the aim of selecting for minority 
bacterial populations. Each set of treatment conditions was observed at least on day 1 
and after one week, 2 weeks and 1 month of incubation to isolate colonies. Blood 
culture bottles were monitored until two months after inoculation. In addition, we 
applied 12 supplementary culture condition treatments. Among them, we developed 
empirically new culture media based on randomly chosen products belonging to the 
dietary habits of the patient: banana, camembert and yogurt.
Identification by mass spectrometry (MALDI-TOF):
Each of the 12,700 samples was covered with 2 mL of matrix solution 
(saturated α-cyano acid-4-hydroxycinnamic in 50% acetonitrile and 2.5% 
trifluoroacetic acid). This analysis was performed using a MICROFLEX spectrometer 
(Bruker Daltonics) according to the manufacturer’s recommendations. For each 
spectrum, a maximum of 100 peaks were used, and these peaks were compared with 
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the computer databases at the Bruker base and the base-specific laboratory at La 
Timone hospital. We previously updated our database with the spectra of the new 
bacterial species cultured during our previous study. An isolate was labeled as 
correctly identified at the species level when at least one spectrum presented a score ≥ 
1.9, and a spectrum had a score of ≥ 1.7 [84]. Every non-identified colony was 
verified three times. When a strain remained unrecognized, the 16S RNA gene was 
sequenced as previously described. All of the spectra of the species identified based 
on 16S rRNA sequencing have been added to the database. The software MALDI 
BIOTYPER 3 was a helpful tool for the classification of the non-identified isolates 
based on comparison of their spectra. Only one strain per group of strains with similar 
spectra was sequenced, while the other strains were verified via MALDI-TOF after 
adding the spectrum to the database.
DNA extracted from fungi isolated from plates was amplified with the primers 
ITS1/ITS4R and identified by direct sequencing (as described below).
16S rRNA amplification and sequencing of the unidentified bacteria:
For nucleotide sequence analyses, bacterial DNA was extracted using the 
MagNA Pure LC DNA isolation kit III (Roche) and a MagNA Pure LC instrument. The 
16S rRNA gene was amplified via PCR using the universal primer pair fd1 and rp2 and 
an annealing temperature of 52°C. The obtained PCR products were purified using the 
NucleoFast 96 PCR kit (Macherey-Nagel). Sequencing reactions were carried out with 
the Big Dye Terminator Sequencing Kit, version 1.1 (Perkin-Elmer) using the primers 
536F, 536R, 800F, 800R, 1050F, and 1050R. The products of the sequencing reactions 
were purified and were analyzed using an ABI PRISM 3130x Genetic Analyzer 
(Applied Biosystems). The obtained sequences were compared with the sequences 
available in the GenBank database using BLAST. A threshold similarity value of 
>98.7% was chosen for identification at the species level [85]. Below this value, a new 
species was suspected, and the isolate was characterized in detail using phenotypic 
analyses and electron microscopy. All sequences of the new species have been deposited 
in GenBank database with the accession numbers: JX041639 and from JX101683 to 
JX101692.
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Genome sequencing
The 11 new bacterial genera and species were grown on 5 to 10 blood agar plates 
in Petri dishes. The biomass was resuspended in 750 µl of TE buffer. Each sample was 
divided into 7 replicates of 100 µl each. The samples were lysed using a mechanical 
treatment on the FastPrep-24 Sample Preparation System device (M.P. Biomedicals, 
USA) followed by a lysozyme treatment at 20 mg/ml and an incubation for 30 min at 
37°C. The preparations were then extracted on an EZ1 advanced XL device (Qiagen, 
Courtaboeuf, France) with kit and electronic card “bacteria”. Each sample was eluted 
into 7 aliquots of 50 µL Tris-HCL (10 mM) and concentrated on a Qiamp column 
(Qiagen Courtaboeuf, France) in 100 µL of AE buffer. The DNA concentration was 
measured using a QuAnt-iT picogreen kit (Invitrogen) on a Tecan Genios fluorometer. A 
paired-end strategy was chosen for the high-throughput pyrosequencing on the 454-
Titanium instrument. The 5 PicoTierPlate PTPs were loaded in 4 regions. An aliquot of 
5 µg of DNA was fragmented in the range of 3-4 Kb on the Hydroshear device 
(GeneMachines, USA). The libraries were constructed according to the manufacturer’s 
instructions for the 454-Titanium paired-end protocol. Each library was clonally 
amplified with 1 cpb in 4 emPCR reactions with the GS Titanium SV emPCR kit (Lib-
L) v2. The yield of the titration was distributed in a range of 12 to 22%. A total of 
790,000 beads per project and per region was loaded on the GS Titanium PicoTiterPlate 
PTP 70x75 kit and sequenced with the GS Titanium Sequencing XLR70 kit. The runs 
were performed overnight and then analyzed in cluster. The de novo assembly of the 
genome sequences was performed using the Newbler 2.5.3 program.
Pyrosequencing
Fecal DNA was extracted from the samples using the NucleoSpin® Tissue Mini Kit 
(Macherey Nagel, Hoerdt, France) with a previously described protocol [86]. A 577 nt 
region of the 16S rRNA gene was amplified via PCR with the primers 917F (5’-
GAATTGACGGGGRCCC) and 1391R (5’-GACGGGCGGTGWGTRCA). These 
primers were selected because they can amplify the hypervariable V6 region (950 to 
1,080 bp) and because they produce an amplicon length equivalent to the average length 
of the reads produced by GS FLX Titanium. High-throughput sequencing was realized 
via unidirectional sequencing. The forward and reverse primers were designated 
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ShotA_917F (CCATCTCATCCCTGCGTGTCTCCGACTCAGGAATTGACGGGGRC
CC) and 
ShotB_1391R (CCTATCCCCTGTGTGCCTTGGCAGTCTCAGGACGGGCGGTGW
GTRCA). The amplicon library was generated based on a simple PCR assay using 1 µL 
of DNA template, extracted as described above, and a pair of special fusion primers 
composed of two parts with two approaches. PCR amplifications were performed in a 
volume of 20 µL over 30 cycles using Taq Phusion (FinnZymes, Thermo Scientific). 
The applied PCR reagents and thermocycling parameters were those suggested in the 
protocol (the annealing temperature was optimal at 58 °C, and the elongation time was 
30 sec, with a final elongation time of 10 min). Amplicon lengths were visualized using 
the BioAnalyzer DNA 7500 labchip at 544 bp. The obtained products were purified as 
recommended using Ampure beads (Agencourt) and quantified via measurement in a 
fluorometer according to the 454_Roche Amplicon Library Preparation Method 
Manual. The unidirectional library was amplified with 1.5 cpb using the GS Titanium 
LV emPCR Kit (Lib-L). This project was loaded onto one-half of a GS Titanium 
PicoTiterPlate PTP Kit 70x75 and sequenced with the GS Titanium Sequencing Kit 
XLR70. 
The raw 16S pyrosequencing data were trimmed based on the SOP procedure 
[87] and using the mothur software package, version 1.2.5 [88]. The reads were 
trimmed using a minimum average quality score of 35 in a windows size of 50 
nucleotides. Only the reads with a minimum length of 180 pb were kept. The data was 
dereplicated and aligned using the SILVA reference bacteria alignment. After pre-
clustering [89] the trimmed reads were also checked for chimera using an 
implementation of the Uchime program in the mothur package. A distance matrix was 
build and Operational Taxonomic Units were defined using a dissimilarity cut-off of 
0.03. The representative sequence of each OTUs was assigned at the genus level using 
the RDP classifier and the RDP training set 9 (http://www.mothur.org/). A database 
was created using criteria selected from the Hierarchy Browser of the RDP 16S rRNA 
database release 10 (http://rdp.cme.msu.edu/). A “Type” database was built with 
sequences labeled “Type strains”, “Isolates” and “length >1200 bp” with “good 
quality”. The database was formatted using Taxcollector [90]. Species-level 
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identification was defined with a minimum sequence identity of 98.7%  [91] with the 
unique best Blast hit from the “Type” database. Graphic model of pyrosequencing and 
culture results (Fig. 2) has been assembled using Cytoscape software [92].
RESULTS
Culturomics
Bacterial species cultured
We analyzed 12,700 colonies using mass spectrometry (MALDI-TOF). Using 
the aforementioned strategy, we identified 133 different bacterial species from 4 phyla, 
including 11 previously undescribed bacterial species (Table 1, 2, Fig. 1, 2 and S1). 
These species included 79 Firmicutes species (59.4%), 25 Actinobacteria species 
(18.8%), 18 Bacteroidetes species (13.5%) and 11 Proteobacteria species (8.3%). We 
cultured 57 different bacterial genera, including 19 different species of Clostridium, 
which was the most represented genus (14%), 16 species of Bacillus (12%) and 9 
species of Bacteroides (7%). 
Identification strategy
Among the  colonies  tested  by MALDI-TOF only 206 colonies  could  not  be 
directly identified with this technique (Fig. S2). Considering that each non-identified 
colony was verified by three passages through MALDI-TOF, approximately 5% of the 
spots were not identified. A MALDI Biotyper allowed us to classify these colonies into 
57 different clusters. The majority of the strains that could not be identified emerged 
during  the  10  first  weeks.  After  identification  via  16S  rRNA  amplification  and 
sequencing and the addition of the spectra to the MALDI-TOF database, the number of 
non-identified species was reduced to an average of 5 strains per week (Fig. S2).
Among the 57 sequenced strains, we identified 31 different types of bacteria, of 
which 11 were new species, and 20 were previously known species that were not 
identified via MALDI-TOF. Among these 20 species, 8 previously had no spectra 
available in the spectrometry database used for this study, and 12 species had an 
insufficient number of spectra in the database to allow identification. The discrepancy 
between the number of sequenced strains and the number of different bacteria can be 
explained by 3 contaminants (Staphylococcus spp.) that were tested erroneously and 23 
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strains that were tested to confirm the first identification or because of insufficient 
clustering that did not cluster 2 specimens of the same species into one group. All of the 
spectra for these species have been added to the spectrometry database to facilitate the 
rapid identification of colonies.
Bacterial species from the human gut: 
Of the 133 species of bacteria cultured, 114 (85.7%) have already been described 
in the human gut. The previous culturomics studies have allowed to identify 349 
different bacteria. From this sample, we identified by culturomics, 36 supplementary 
bacterial species including 11 new species, eight species that have been previously 
described but not isolated from the human gut, including 3 Actinobacteria 
(Corynebacterium ureicelerivorans, Microbacterium aurum, Kytococcus sedentarius), 4 
Firmicutes (Bacillus marislfavi, Lysinibacillus fusiformis, Facklamia tabacinasalis, 
Bacillus polyfermenticus) and 1 Bacteroidetes (Chryseobacterium hominis) and 17 
species previously known from human gut. Among these 36 bacteria first isolated by 
culturomics, 20 bacterial species grew preferentially or strictly in anaerobic conditions. 
In addition, 25 species of the previously known bacterial species (22%) have only once 
been described from the human gut by previous culturomics studies [81], [47]. 
Moreover, 4 bacterial species, Peptoniphilus grossensis (GenBank JF837491),  
Peptoniphilus timonensis (GenBank JN657222), Bacillus massiliosenegalensis 
(GenBank JF824800), and Actinomyces grossensis (GenBank JF837492), that were first 
isolated in our previous study were also isolated from the stool sample studied here 
(Table 1) [79]. 
New bacterial species:
The new bacterial species included nine new species from three phyla and two 
new genera. Among these isolates, we cultured fivr Firmicutes species “Candidatus 
Holdemania massiliensis” (JX101683), “Candidatus Dorea massiliensis” (JX101687),  
“Candidatus Clostridium anorexicus” (JX101685), “Candidatus Clostridium 
anorexicamassiliense” (JX101686), “Candidatus Bacillus marseilloanorexicus” 
(JX101689), two Actinobacteria species “Candidatus Streptomyces massiliensis” 
(JX101691)  and “Candidatus Blastococcus massiliensis” (JX101684) and 2 
Bacteroidetes species “Candidatus Bacteroides timonensis” (JX041639) and 
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“Candidatus Alistipes marseilloanorexicus” (JX101692) for the first time. The 2 new 
genera are represented by “Candidatus Stoquefichus massiliensis” (JX101690) and 
“Candidatus Soleaferrea massiliensis” (JX101688), of the Firmicutes phylum. 
“Candidatus Soleaferrea massiliensis” was so named because it resembles a horseshoe 
(Fig. S1). The names of the new species have been selected preferentially in the 
reference of ‘Marseille’, our laboratory's city or ‘Timone’ for the hospital where our 
laboratory is localized, as previously employed [81], [47]. In the cases where the species 
name has been already used, we added “anorexica” with “massiliensis” in reference of 
the source of the sample, although no link exists between the clinical status and these 
new bacterial species. All of these species were deposited in the Collection de Souches 
de l’Unité des Rickettsies (CSUR).
Culture conditions for new species
Eight out of the 11 new bacterial species and genera require anaerobic conditions 
for growth. Among the 8 anaerobic bacteria, one was cultured after a long incubation (1 
month) in 5% sheep blood agar; one was cultured at 28°C; and 5 were isolated after 
preincubation in a blood culture bottle with or without sheep blood and sheep rumen 
fluid to mimic the natural environment, as proposed by environmental microbiologists 
[65] (Table 2 and S1).
Genome sequencing
Each new species will be described using the new concept of microbiogenomics, 
adding the MALDI-TOF spectra and genome sequences to the classical description. Ten 
out of the 11 new bacterial species and genera isolated from stool sample have already 
been sequenced (Table 1, Table S1), generating a total of 41.2 Mb unique sequence. The 
genomes sizes of the new bacteria ranged from 2.75 Mb to 7.13 Mb (Table 1B). Based 
on our previous results, altogether, the present work yielded approximately at least 
3,000 previously unknown genes.
Culture conditions: 
Among the 133 bacterial isolates (Table 1), 130 (97.7%) were identified using 70 
different types of basic culture conditions (Table S3), selected because they had allowed 
to identify the 340 different bacterial species in our seminal study [47]. The culture 
condition that produced the best yield was preincubation in an anaerobic blood culture 
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bottle with thioglycolate, from which 49 species (37%) were isolated. Anaerobic 
incubation directly on 5% sheep blood agar led to 8 additional species being identified 
(Bacteroides caccae, B. fragilis, B. nordii, Butyricimonas virosa, Corynebacterium 
amycolatum, Parabacteroides goldsteinii, Staphylococcus saprophyticus, Streptococcus 
salivarius), and passive filtration in Leptospira broth resulted in 6 additional species 
(Bacillus marisflavi, B. pumilus, B. flexus, Brevibacillus borstelensis, Enterococcus 
avium, Paenibacillus barengoltzii). Three species (Enterobacter cloacae, Bacillus  
clausii and Staphylococcus cohnii) were identified using newly designed culture 
conditions.
Pyrosequencing
The pyrosequencing analysis generated 83,951 reads. The abundance of reads 
classified at the phylum level was 64,216 reads from Firmicutes (76.49%), 8,439 reads 
from Actinobacteria (10.05%), 4,983 from Bacteroidetes (5.94%), 2,434 from 
Proteobacteria (2.9%), 25 for Cyanobacteria/Chloroplasts (0.03%), 17 from 
Synergistetes (0.02%), and 2 from Verrucomicrobia. Finally, 3,834 reads (4.57%) were 
not assigned at the phylum level and were designated as unclassified. 
Diversity was represented by 1,273 different OTUs. Of these OTUs, 1,026 were 
assigned to the Firmicutes phylum, 86 to the Actinobacteria phylum, 58 to the 
Bacteroidetes phylum, 32 to the Proteobacteria phylum, and 66 different OTUs 
remained unclassified. Among the OTUs assigned to the Firmicutes, 22% belonged to 
the Clostridium genus and 16 % to the Oscillibacter genus, while 37 % remained 
unclassified at the genus level. Among the OTUs assigned to the Actinobacteria 
phylum, most belonged to the Bifidobacteria genus (62%).
Comparison between microbial culturomics and pyrosequencing results: 
A dramatic difference was observed between the groups of microbial species 
identified by culturomics and by pyrosequencing. At the species level, only 23 of the 
isolates were common to the two approaches (17% of the culturomics group) (Fig. 2). 
The 10 most abundant OTUs assigned to the species level corresponded to 13,979 reads 
(16.7%). Among these species, 5 bacteria, representing 9% of the total of reads 
(Bifidobacterium animalis, Clostridium ramosum, Turicibacter sanguinis,  
Streptococcus salivarius, Bacteroides uniformis), were concomitantly cultured. In 
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addition, without taking into account the species detected by both techniques, more of 
the half of the sequences (45,317 reads) were assigned to Ruminococcaceae, 
Erysipelotrichaceae or Lachnospiraceae families respectively, that are constituted by 
strictly anaerobic species.
DISCUSSION
Here, we carried out the first study combining microbial culturomics and 
pyrosequencing in the gut of an anorexia nervosa patient and we have been lucky 
enough to isolate for the first time 11 completely new species. As mass spectrometry is 
used in routine bacteriological analyses, including in two previous culturomics study 
[81], [47] completed using 16S rRNA amplification and sequencing [85] for 
unidentified colonies, we are confident in the results of this study [84]. Genome 
sequencing has been performed as previously described [68]–[79]. In parallel, we 
conducted pyrosequencing of 16S rRNA amplicons targeting the hypervariable V6 
region, previously described as a reference method for analyses of the human gut [93], 
[82], [47]. The large-scale nature of this work involving complementary techniques 
explains why we analyzed only a single stool sample. Nevertheless, the uniqueness of 
these results (19 bacterial species first described from human gut including 11 new 
bacterial species and genome sequences) allows us to draw useful information about the 
gut microbiota repertoire [47]. 
The 11 new bacterial species isolated in this study demonstrate that each stool 
sample studied by culturomics in a particular condition (here anorexia nervosa) can lead 
to a significant increase in the number of new bacterial species isolated from the gut 
microbiota (Fig. 1 and 2). These 11 new species cultured from a single stool sample 
demonstrates the potential of this technique [94] when compared to only 8 species from 
human gut microbiota described  in International Journal of Systematic and 
Evolutionary Microbiology during the 2 last years! As a matter of fact, from the 5 stools 
published using culturomics so far, we have identified 42 new bacterial species 
comparable to these validated in IJSEM by the rest of the world  from human gut  since 
5 years (Fig. 1) [81], [47]. As this are pioneering studies, only the extension of this 
strategy will allow to determine if these new species are linked to the clinical and 
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epidemiological patients status studied (rural healthy African individuals, obese and 
anorexic French patients, patients treated with wide-spectrum antibiotics) [81], [47]. 
Four new bacterial species discovered in our first culturomics study have been cultured 
in this sample (Table 1). When a higher number of stool samples will be studied by 
culturomics, specific PCR will be designed for each 42 new bacterial species in the aim 
to associate these with different clinical status. In addition, if a link between new 
bacterial species and clinical status was highlighted, molecular tools will be easily used 
to study the evolution of gut microbiota composition after treatment.
The pyrosequencing results highlighted, as previously reported, a low 
overlapping with culturomics results with only 17 % of the species detected by the 2 
techniques. In addition, most of the OTU detected only by pyrosequencing were 
assigned mainly to Ruminococcaceae, Lachnospiraceae and Erysipelotrichaceae 
families which are constituted by stringent anaerobic species. The best future route for 
culturomics will be to improve the anaerobic culture conditions.  As previously 
reported, we could propose, in the future, to collect fecal samples directly in containers 
with a gas generation system and to transport immediately at 4°C before processing in 
an adapted anaerobic chamber in the aim to reduce the redox potential [95] and the 
bacterial viability reduction caused by freezing [83], or use roll-tubes initially designed 
for the methanogenic archaeal species culture [96]. Finally, we could use supplementary 
culture conditions with various antibiotics with different critical concentration in the 
aim to select minority bacterial populations [97].
In conclusion, this approach using microbial culturomics and culture-
independent techniques has been yet incredibly fertile to describe new microbes from 
human gut microbiota. In the future, pyrosequencing results will help to design specific 
new culture conditions for the more represented bacterial families. Once the repertoire 
will be comprehensively described, supplementary studies with more samples will 
connect the gut microbiota composition with the clinical or geographical status. 
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Table 1. Bacterial species identified via culture. The 19 bacterial species described from 
the human gut for the first time in this work are presented in bold.
Phylum Species Phylum Species
Actinobacteria Actinomyces grossensis Firmicutes Clostridium baratii
Adlercreutzia equolifaciens Clostridium bifermentans
Aeromicrobium massiliense Clostridium butyricum
Arthrobacter castelli Clostridium citroniae
Blastococcus massiliensis Clostridium glycolycum
Bifidobacterium animalis Clostridium hathewayi
Cellulosimicrobium cellulans Clostridium inocuum
Collinsella aerofaciens Clostridium orbiscindens
Corynebacterium afermentans Clostridium oroticum
Corynebacterium amycolatum Clostridium paraputrificum
Corynebacterium mucifaciens Clostridium perfringens
Corynebacterium tuberculostearicum Clostridium ramosum
Corynebacterium ureicelerivorans Clostridium scindens
Dermabacter hominis Clostridium sordellii
Eggerthella lenta Clostridium sporogogenes
Gordonibacter pamelaeae Clostridium symbiosum
Kytococcus schroeteri Clostridium tertium
Kytococcus sedentarius Coprobacillus cateniformis
Microbacterium aurum Dorea massiliensis
Micrococcus luteus Enterococcus avium
Micrococcus lylae Enterococcus casseliflavus
Propionibacterium acnes Enterococcus faecalis
Rothia aeria Enterococcus faecium
Rothia dentocariosa Eubacterium limosum
Streptomyces massiliensis Eubacterium tenue
Bacteroidetes Alistipes marseilloanorexicus Facklamia tabacinasalis
Alistipes onderdonkii Finegoldia magna
Bacteroides cellulosilyticus Holdemania massiliensis
Bacteroides caccae Lactobacillus  rhamnosus
Bacteroides fragilis Lactobacillus paracasei
Bacteroides nordii Lactococcus lactis
Bacteroides ovatus Lysinibacillus fusiformis
Bacteroides thetaiotaomicron Negativococcus succinicivorans
Bacteroides timonensis Paenibacillus barcinonensis
Bacteroides uniformis Paenibacillus barengoltzii
Bacteroides vulgatus Peptinophilus grossensis
Barnesiella intestinihominis Peptinophilus timonensis
Butyricimonas virosa Soleaferrea massiliensis
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Chryseobacterium hominis Staphylococcus aureus
Parabacteroides goldsteinii Staphylococcus capitis
Parabacteroides distasonis Staphylococcus caprae
Parabacteroides merdae Staphylococcus cohnii
Porphyromonas somerea Staphylococcus epidermidis
Firmicutes Bacillus badius Staphylococcus haemolyticus
Bacillus cereus Staphylococcus hominis
Bacillus circulans Staphylococcus pasteuri
Bacillus clausii Staphylococcus saprophyticus
Bacillus flexus Staphylococcus warneri
Bacillus licheniformis Stoquefichus massiliensis
Bacillus marisflavi Streptococcus gordonii
Bacillus marseilleoanorexicus Streptococcus mitis
Bacillus megaterium Streptococcus oralis
Bacillus polyfermenticus Streptococcus parasanguinis
Bacillus pumilus Streptococcus pneumoniae
Bacillus senegalensis Streptococcus salivarius
Bacillus simplex Turicibacter sanguinis
Bacillus sonorensis Proteobacteria Bilophila wadsworthia
Bacillus subtilus Citrobacter freundii
Bacillus vallismortis Enterobacter cloacae
Blautia coccoides Escherichia coli
Blautia hydrogenotrophica Escherichia hermannii
Brevibacillus  borstelensis Klebsiella pneumoniae
Brevibacillus agri Moraxella osloensis
Catabacter hongkongensis Neisseria flavescens
Clostridium anorexicamassiliense Neisseria perflava
Clostridium anorexicus Pantoea agglomerans
Proteus mirabilis
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Table 2.  Main characteristics of the new bacterial species and respective genome sequence.
Phylum Bacterial species Culture 
condition
16S number Bioproject 
number
Genome size
Firmicutes Soleaferrea massiliensis Inoculation in blood culture bottle, 5% sheep blood 
agar, anaerobe, 37°C
JX101688 PRJEB375 In progress
Stoquefichus massiliensis 5% sheep blood agar, anaerobe, 28°C JX101690 PRJEB377 3,46Mb
Dorea massiliensis Inoculation in blood culture bottle + rumen fluid, 
5% sheep blood agar, anaerobe, 37°C
JX101687 PRJEB374 3,6Mb
Holdemania massiliensis Inoculation in blood culture bottle + Thioglycolate, 
5% sheep blood agar, anaerobe, 37°C
JX101683 PRJEB187 3,8 Mb
Clostridium anorexicus Inoculation blood culture bottle + sheep blood, 5% 
sheep blood agar, anaerobe, 37°C
JX101685 PRJEB372 3,52Mb
Clostridium anorexicamassiliense Inoculation blood culture bottle + sheep blood, 5% 
sheep blood agar, anaerobe, 37°C
JX101686 PRJEB373 4,42Mb
Bacillus marseilloanorexicus Inoculation in blood culture bottle 1 month + rumen 
fluid, 5% sheep blood agar, aerobe, 37°C
JX101689 PRJEB376 4,62Mb
Bacteroidetes Bacteroides timonensis 5% sheep blood agar 1 month, anaerobe, 37°C, JX041639 PRJEB186 7,13Mb
Alistipes marseilloanorexicus Inoculation in blood culture bottle + Thioglycolate, 
5% sheep blood agar, anaerobe 37°C
JX101692 PRJEB379 2,75Mb
Actinobacteria Streptomyces massiliensis Filtration 0,45µm,  Brain Heart Infusion agar, 
aerobe, 37°C
JX101691 PRJEB378 In progress
Blastococcus massiliensis Brucella agar, aerobe 37°C JX101684 PRJEB371 3.87 Mb
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Table 3. OTUs assigned to the species level identified via pyrosequencing.
Phylum Species Phylum Species
Actinobacteria Actinomyces odontolyticus Firmicutes Clostridium saccharoperbutylacetonicum
Asaccharobacter celatus Clostridium scindens
Bifidobacterium animalis Clostridium spiroforme
Collinsella aerofaciens Clostridium vincentii
Eggerthella lenta Enterococcus saccharolyticus
Propionibacterium acnes Eubacterium callanderi
Rothia mucilaginosa Eubacterium tenue
Bacteroidetes Alistipes putredinis Lactobacillus rogosae
Alistipes shahii Lactococcus raffinolactis
Bacteroides caccae Lactonifactor longoviformis
Bacteroides fragilis Parvimonas micra
Bacteroides ovatus Pediococcus damnosus
Bacteroides thetaiotaomicron Phascolarctobacterium faecium
Bacteroides uniformis Pseudoflavonifractor capillosus
Parabacteroides distasonis Roseburia faecis
Firmicutes Brevibacterium massiliense Roseburia hominis
Clostridium aldenense Roseburia intestinalis
Clostridium asparagiforme Ruminococcus flavefaciens
Clostridium baratii Ruminococcus torques
Clostridium bartlettii Staphylococcus aureus
Clostridium celatum Streptococcus mutans
Clostridium chauvoei Streptococcus salivarius
Clostridium glycolicum Turicibacter sanguinis
Clostridium 
glycyrrhizinilyticum
Veillonella rogosae 
Clostridium leptum Proteobacteria Enterobacter cloacae
Clostridium orbiscindens Pelomonas saccharophila
Clostridium oroticum Serratia ficaria
Clostridium perfringens Verrucomicrobia Akkermansia muciniphila
Clostridium ramosum
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Table 4. Bacterial species and OTUs assigned to the species level identified via both 
pyrosequencing and culture
Phylum Species
Actinobacteria Bifidobacterium animalis
Collinsella aerofaciens
Eggerthella lenta
Propionibacterium acnes
Bacteroidetes Bacteroides caccae
Bacteroides fragilis
Bacteroides ovatus
Bacteroides thetaiotaomicron
Bacteroides uniformis
Parabacteroides distasonis
Parabacteroides merdae
Firmicutes Clostridium baratii
Clostridium glycolicum
Clostridium orbiscindens
Clostridium oroticum
Clostridium perfringens
Clostridium ramosum
Clostridium scindens
Eubacterium tenue
Staphylococcus aureus
Streptococcus salivarius
Turicibacter sanguinis
Proteobacteria Enterobacter cloacae
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Fig. 1 Number of bacterial species found in the human gut validated in the literature and 
isolated via culturomics between 2000 and 2012 (A) and the proportion of bacterial species 
validated or isolated by culturomics each year (B).
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Fig. 2 Comparison of the pyrosequencing and culture results. Broken lines containing points 
and dashes represent new bacterial species, while a simple dotted line represents a species 
isolated for the first time from the human gut. Different colors represent each phylum: red, 
Firmicutes; orange, Bacteroidetes; yellow, Actinobacteria; pink, Proteobacteria; and light 
yellow, Verrucomicrobia.
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Fig. S1. Phylogenetic trees of the new species cultured: A: Dorea massiliensis B: 
Holdemania massiliensis C: Alistipes marseilloanorexicus D: Bacteroides timonensis E: 
Clostridium anorexicamassiliense and Clostridium anorexicus F: Soleaferrea massiliensis G: 
Streptomyces massiliensis H: Stoquefichus massiliensis I: Bacillus marseilloanorexicus J: 
Blastococcus massiliensis
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Fig. S2. Evolving progress of culturomics. Visual representations of the number of colonies 
tested each week (A); the number of non-identified species isolated each week (B); and of the 
number of supplementary species identified each week (C). No plateau was observed in the 
number of supplementary species identified.
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Table S1: Description of the 88 culture conditions used.
Basic culture conditions
COS, anaerobic 37°C BHI + filtered stool, aerobic 37°C Schaedler, anaerobic 37°C 
COS, anaerobic 28° C BHI + sheep blood, aerobic 37°C Sabouraud, anaerobic 37°C 
COS, 5µm anaerobic 37°C BHI + Colimycine + Vancomycine, aerobic 37°C MRS, anaerobic 37°C 
COS, µaerobic 37°C BHI + Vancomycine, aerobic 37°C Schaedler KV, anaerobic 37°C 
COS, aerobic 25°C Mueller Hinton + Vancomycine, aerobic 37°C BHI + sheep blood, anaerobic 37°C 
COS, aerobic 37°C BHI, filtration 0,45µm, aerobic 37°C BHI, filtration 5µm, anaerobic 37°C 
Orange, aerobic 37°C BHI, filtration 5µm, aerobic 37°C Leptospira, passive filtration, µaerobic 37°C
Marin, aerobic 28°C BHI + 15g/l NaCl, aerobic 37°C BSKH, passive filtration, aerobic 37°C
MOD4, aerobic 37°C BHI + 3g/l NaCl, aerobic 37°C Mueller Hinton, aerobic 37°C
BCP, aerobic 37°C BHI + 1g/l NaCl, aerobic 37°C HTM, 2,5% CO2 37°C
M17, aerobic 37°C Bordatella, 5%CO2 37°C Shaedler KV, aerobic 37°C
Brucella, aerobic 37°C R2A, aerobic 37°C TSA, aerobic 37°C
EMB, aerobic 37°C PVX, 5%CO2 37°C Wilkins, aerobic 37°C
CaCO3, aerobic 37°C ISP, aerobic 37°C BCYE, 5%CO2 37°C
BCYE, Inoculation blood culture, anaerobic 37°C, D7
BHI, Inoculation blood culture, anaerobic 37°C, D2
BHI, Inoculation blood culture, anaerobic 37°C, 2weeks
Schaedler KV, Inoculation blood culture, anaerobic 37°C
COS, Inoculation blood culture, anaerobic 37°C, D2
COS, Inoculation blood culture, anaerobic 37°C, 2weeks
COS, Inoculation blood culture, anaerobic 37°C, 1month
COS, Inoculation blood culture + Thioglycolate, anaerobic 37°C, D2
COS, Inoculation blood culture + Thioglycolate, anaerobic 37°C, D5
COS, Inoculation blood culture + Thioglycolate, anaerobic 37°C, D10
COS, Inoculation blood culture + Thioglycolate, anaerobic 37°C, 1m
COS, Inoculation blood culture + sheep rumen, anaerobic 37°C, D2
COS, Inoculation blood culture + sheep rumen, anaerobic 37°C, D10
COS, Inoculation blood culture + sheep rumen, anaerobic 37°C, 1m
COS, Inoculation blood culture + sheep rumen, anaerobic 37°C, D7
COS, Inoculation blood culture + sheep rumen + sheep blood, anaerobic 37°C, 1m
COS, Inoculation blood culture + sheep rumen + sheep blood, anaerobic 37°C, D3
COS, Inoculation blood culture + sheep blood, anaerobic 37°C, D2
COS, Inoculation blood culture + sheep blood, anaerobic 37°C, D20
COS, Inoculation blood culture + sheep rumen + filtered stool, anaerobic 37°C, D2
COS, Inoculation blood culture after thermic shock 60°C 20min, anaerobic 37°C
COS, Inoculation blood culture + sheep rumen, aerobic 37°C
COS, Inoculation blood culture after thermic shock 60°C 20min, aerobic 37°C
Supplementary culture conditions
PVX, aerobic 45°C Orange ph6, aerobic 37°C Yoghurt medium, 5% CO2 37°C
PVX, anaerobic 45°C Orange ph6, anaerobic 37°C Yoghurt medium, anaerobic 37°C
PCA, aerobic 37°C Chapman, aerobic 37°C Cheese medium, anaerobic 37°C
Brewer's yeast medium, 5% CO2 37°C Brewer's yeast medium, anaerobic 37°C
COS, Inoculation blood culture bottle + banana, anaerobic 37°C
TSA, Inoculation blood culture bottle + banana, anaerobic 37°C
COS, Inoculation blood culture bottle + cheese, anarobic 37°C
TSA, Inoculation blood culture bottle + cheese, anarobic 37°C
 COS, Inoculation blood culture bottle + brewer's yeast, anarobic 37°C
COS, Inoculation blood culture bottle + yoghurt, anarobic 37°C
COS, Inoculation blood culture + cow rumen, anaerobic 37°C
COS, Inoculation blood culture after filtration 0,8µm, aerobic 37°C
COS, Inoculation blood culture after filtration 0,8µm, anaerobic 37°C
COS, Inoculation blood culture, aerobic 37°C
COS, Inoculation blood culture + sheep blood, aerobic 37°C
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2.2 Publication II:
(To be adjusted to this dissertation, the numbering of tables and figures have been changed in 
the following article by addition of  “2” in front of the initial number.)
Standards in Genomic Sciences (2013) 8:465-479. DOI:10.4056/sigs.4087826 
Non-contiguous finished genome sequence and description of 
Bacillus massilioanorexius sp. nov.
 Ajay Kumar Mishra1, Anne Pfleiderer1†, Jean-Christophe Lagier1, Catherine Robert1, Didier 
Raoult1 and Pierre-Edouard Fournier1*† 
1Aix-Marseille Université, URMITE, Faculté de médecine, France 
*Correspondence: pierre-edouard.fournier@univmed.fr 
†These two authors contributed equally to this work 
Keywords: Bacillus massilioanorexius, genome, culturomics, taxonogenomics 
Abstract
 Bacillus massilioanorexius strain AP8T sp. nov. is the type strain of B. massilioanorexius sp. 
nov., a new species within the genus Bacillus. This strain, whose genome is described here, 
was isolated from the fecal flora of a 21-year-old Caucasian French female suffering from a 
severe form of anorexia nervosa since the age of 12 years. B. massilioanorexius is a Gram-
positive aerobic bacillus. Here we describe the features of this organism, together with the 
complete genome sequence and annotation. The 4,616,135 bp long genome (one chromo-
some but no plasmid) contains 4,432 protein-coding and 87 RNA genes, including 8 rRNA 
genes. 
 Introduction 
Bacillus massilioanorexius strain AP8T  (= CSUR P201 = DSM 26092) is the type strain of B. 
massilioanorexius sp. nov. This bacterium is a Gram-positive, non-spore-forming, aerobic and 
motile bacillus that was isolated from the stool of a 21-year-old Caucasian French female 
suffering from a severe form of anorexia nervosa since the age of 12 years and is part of a 
“culturomics” study aiming at cultivating all species within human feces individually 
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[47][81][98]. This bacterium was one of the 11 new bacterial species isolated from this single 
stool sample [98]. 
The current classification of Bacteria and Archaea remains a subject of debate and currently 
relies on a combination of phenotypic and genotypic characteristics [99]. Genomic data has 
not yet been routinely incorporated into descriptions. However, as more than 6,000 bacterial 
genomes have been sequenced including 982 type strains [100][101] and another 15,000 
genomic projects are ongoing including 2,120 type strains [100][59], we recently proposed to 
integrate genomic information in the description of new bacterial species [68]-[79], [102]-
[111].
The genus Bacillus (Cohn 1872) was created in 1872 [112]. It consists mainly of Gram-
positive, motile, spore-forming bacteria classified within 251 species and 3 subspecies with 
validly published names [113]. Members of the genus Bacillus are ubiquitous bacteria isolated 
from various environments including soil, fresh and sea water and food. In humans, Bacillus  
species may be opportunists in immunocompromised patients or pathogenic, such as B. 
anthracis [84] and B. cereus. However, in addition to these two species, various Bacillus  
species may be involved in a variety of aspecific human infections, including cutaneous, 
ocular, central nervous system or bone infections, pneumonia, endocarditis and bacteremia 
[115]. 
Here we present a summary classification and a set of features for B. massilioanorexius sp. 
nov. strain AP8T  (= CSUR P201 = DSM 26092), together with the description of the complete 
genomic sequence and its annotation. These characteristics support the circumscription of the 
species B. massilioanorexius. 
Classification and information 
A stool sample was collected from a 21-year-old Caucasian French female suffering from a 
severe restrictive form of anorexia nervosa since the age of 12 years. She was hospitalized in 
the nutrition unit of our hospital for recent aggravation of her medical condition. At the time 
of hospitalization, her weight and height was 27.7 kg, and 1.63 m (BMI: 10.4 kg/m2) 
respectively. The patient gave an informed and signed consent. This study and the assent 
procedure were approved by the Ethics Committee of the Institut Fédératif de Recherche 
IFR48, Faculty of Medicine, Marseille, France (agreement 09-022). The fecal specimen was 
preserved at -80°C after collection. Strain AP8T  (Table 21) was isolated in March 2012 by 
aerobic cultivation on Columbia agar (BioMerieux, Marcy l’Etoile, France) after one month 
of preincubation of the stool sample with addition of 5ml of sheep rumen in blood bottle 
culture. This strain exhibited a 97% nucleotide sequence similarity with B. sim-plex [116], t 
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the phylogenetically closest validated Bacillus species (Figure 21). This value was lower than 
the 98.7% 16S rRNA gene sequence threshold recommended by Stackebrandt and Ebers to 
delineate a new species without carrying out DNA-DNA hybridization [85]. 
Different growth temperatures (25, 30, 37, 45°C) were tested. Growth was observed between 
25 and 45°C, with optimal growth at 37°C after 24 hours of incubation. Colonies were 3 mm 
in diameter and 0.5 mm in thickness and gray in color with coarse appearance on blood-
enriched Columbia agar. Growth of the strain was tested under anaerobic and microaerophilic 
conditions using GENbag anaer and GENbag microaer systems, respectively (BioMerieux), 
and under aerobic conditions, with or without 5% CO2. Growth was obtained in all the above 
mentioned conditions except in anaerobic conditions, where weak growth was observed. 
Gram staining showed Gram-positive rods. The motility test was positive. Cells grown on 
agar are Gram-positive rods (Figure 22), have a mean diameter of 0.77 μm and a mean length 
of 2.27 μm in electron microscopy (Figure 23). 
Strain AP8T  exhibited catalase and oxidase activity. Substrates oxidation and assimilation 
were examined with an API 50CH strip (BioMerieux) at the optimal growth temperature. 
Positive reactions were observed for D-glucose, D-fructose, D-saccharose, ribose, mannose, 
mannitol and D-trehalose and weak reactions were observed for L-rhamnose, esculine, 
salicine, D-cellobiose and gentiobiose. Using an API 20E strip (BioMerieux, Marcy l’Etoile), 
positive reactions were observed for tryptophane deaminase, acetoin and gelatinase 
production. Negative reactions were found for urease and indole production. 
B. massilioanorexius is susceptible to amoxicillin, rifampicin, ciprofloxacin, gentamicin, 
doxycycline and vancomycin but resistant to trimethoprim/sulfamethoxazole and 
metronidazole. When compared with representative species from the genus Bacillus, B. 
massilioanorexius strain AP8T  exhibited the phenotypic differences detailed in Table 22. 
Matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF) MS protein analysis 
was carried out as previously described [84] using a Microflex spectrometer (Brüker 
Daltonics, Leipzig, Germany). Twelve individual colonies were deposited on a MTP 384 
MALDI-TOF target plate (Brüker). The twelve AP8T  spectra were imported into the MALDI 
BioTyper software (version 2.0, Brüker) and analyzed by standard pattern matching (with 
default parameter settings) against the main spectra of 3,769 bacteria, including 129 spectra 
from 98 validly named Bacillus species, used as reference data in the BioTyper database. A 
score enabled the presumptive identification and discrimination of the tested species from 
those in a database: a score > 2 with a validated species enabled the identification at the spe-
cies level; and a score < 1.7 did not enable any identification. For strain AP8T , no significant 
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score was obtained, suggesting that our isolate was not a member of any known species 
(Figures 24 and 25). 
Genome sequencing information 
Genome project history 
The organism was selected for sequencing on the basis of its phylogenetic position and 16S 
rRNA similarity to other members of the Bacillus genus, and is part of a “culturomics” study 
of the human digestive flora aiming at isolating all bacterial species within human feces. It 
was the twentyseventh genome of a Bacillus species and the first genome of Bacillus  
massilioanorexius sp. nov. A summary of the project information is shown in Table 23. The 
Genbank accession number is CAPG00000000 and consists of 120 contigs. Table 23 shows 
the project information and its association with MIGS version 2.0 compliance [117]. 
Growth conditions and DNA isolation 
Strain AP8T  was grown aerobically in Columbia broth (BioMerieux, Marcy l’Etoile, France). 
Extraction of chromosomal DNA was performed by using 50 mL of 48-72 h culture of B. 
massilioanorexius, centrifuged at 4°C and 2000 × g for 20 min. Resuspension of cell pellets 
was done in 1 mL Tris/EDTA/NaCl [10mM Tris/HCl (pH7.0), 10 mM EDTA (pH8.0), and 
300 mM NaCl] and recentrifugation was done under the same conditions. The pellets were 
resuspended in 200μL TE/lysozyme [25 mM Tris/HCl (pH8.0), 10 mM EDTA (pH8.0), 10 
mM NaCl, and 10 mg lysozyme/mL]. The sample was incubated at 37°C for 30 min and then 
30 μL of 30% (w/v) sodium N- lauroyl-sarcosine (Sarcosyl) was added to it, incubated for 20 
min at 65°C, followed by incubation for 5 min at 4°C. Purification of DNA with phe-
nol/chloroform/isoamylalcohol (25:24:1) was followed by precipitation with ethanol. DNA 
concentration was 64.3 ng/μl as determined by Genios Tecan fluorometer, using the Quant-it 
Picogreen kit (Invitrogen). 
Genome sequencing and assembly 
A 3kb paired-end sequencing strategy (Roche, Meylan, France) was used. Five μg of DNA 
were mechanically fragmented on the Covaris device (KBioScience-LGC Genomics, 
Middlesex, UK) through miniTUBE-Red with an enrichment size at 3-4kb. The DNA 
fragmentation was visualized through the Agilent 2100 BioAnalyzer on a DNA labchip 7500 
with an optimal size of 2.95 kb. The library was constructed according to the 454 GS FLX 
Titanium paired-end protocol. Circularization and nebulization were performed which 
generated a pattern of 553 bp optimal size. PCR amplification was performed for 17 cycles 
followed by double size selection. The single stranded paired-end library was quantified using 
Quant-it Ribogreen kit (Invitrogen) with Genios Tecan fluorometer that yielded concentration 
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of 556 pg/μL. The library concentration equivalence was calculated as 1.82E+09 
molecules/μL. The library was stored at -20°C until further use. 
The shotgun library was clonally amplified with 5cpb in 4 emPCR reactions and the 3kb 
paired end library was amplified with lower cpb in 4 emPCR reactions at 1cpb and 2 emPCR 
at 0.5 cpb with the GS Titanium SV emPCR Kit (Lib-L) v2 (Roche). The yield of the shotgun 
emPCR reactions was 16.9 and 5.62% respectively for the two kinds of paired-end emPCR 
reactions according to the quality expected (range of 5 to 20%) from the Roche procedure. 
Two libraries were loaded on the GS Titanium PicoTiterPlates (PTP Kit 70x75, Roche) and 
pyrosequenced with the GS Titanium Sequencing Kit XLR70 and the GS FLX Titanium 
sequencer (Roche). The run was performed overnight and analyzed on the cluster through the 
gsRunBrowser and Newbler assembler (Roche). A total of 410,883 passed filter wells were 
obtained and generated 144.49 Mb with a length average of 344 bp. The passed filter 
sequences were assembled Using Newbler with 90% identity and 40 bp as overlap. The final 
assembly identified 20 scaffolds and 120 contigs and generated a genome size of 4.61Mb 
which corresponds to a coverage of 31.34 × genome equivalent. 
Genome annotation 
Open Reading Frames (ORFs) were predicted using Prodigal [118] with default parameters 
but the predicted ORFs were excluded if they were spanning a sequencing gap region. The 
predicted bacterial protein sequences were searched against the GenBank database [119] and 
the Clusters of Orthologous Groups (COG) databases using BLASTP. The tRNAScanSE tool 
[120] was used to find tRNA genes, whereas ribosomal RNAs were found by using 
RNAmmer [121] and BLASTn against the GenBank database. Lipoprotein signal peptides 
and the number of transmembrane helices were predicted using SignalP [122] and TMHMM 
[123]  respectively. ORFans were identified if their BLASTP E-value was lower than 1e-03 for 
alignment length greater than 80 amino acids. If alignment lengths were smaller than 80 
amino acids, we used an E-value of 1e-05. Such parameter thresholds have already been used 
in previous works to define ORFans. Ortholog sets composed of one gene from each of six 
genomes (B. massilioanorexius strain AP8T , B. timonensis strain DSM 25372 (GenBank 
accession number CAET00000000), B. amyloliquefaciens strain FZB42 (GenBank accession 
number NC_009725), B. massiliosenegalensis strain JC6T (GenBank accession number 
CAHJ00000000), B. mycoides strain DSM 2048 (GenBank accession number CM000742) 
and B. thuringiensis strain BMB171 (GenBank accession number CP001903),) were 
identified using the Proteinortho software (version 1.4) [124] using a 30% protein identity and 
1e-05 E-value. The average percentage of nucleotide sequence identity between corresponding 
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orthologous sets were determined using the Needleman-Wunsch algorithm global alignment 
technique. Artemis [125] was used for data management and DNA Plotter [126] was used for 
visualization of genomic features. Mauve alignment tool was used for multiple genomic 
sequence alignment and visualization [127]. 
Genome properties 
The genome of B. massiliensis strain AP8T  is 4,616,135 bp long (1 chromosome, but no plas-
mid) with a 34.10% G + C content (Figure 26 and Table 24). Of the 4,519 predicted genes, 
4,432 were protein-coding genes, and 87 were RNAs. Eight rRNA genes (one 16S rRNA, one 
23S rRNA and six 5S rRNA) and 79 predicted tRNA genes were identified in the genome. A 
total of 3,290 genes (72.80%) were assigned a putative function. Three hundred fifty-four 
genes were identified as ORFans (7.98%). The remaining genes were annotated as 
hypothetical proteins. The properties and the statistics of the genome are summarized in Table 
24 and Table 5. The distribution of genes into COGs functional categories is presented in 
Table 25. 
Comparison with other Bacillus species genomes 
Here, we compared the genome of B. massilioanorexius strain AP8T , B. timonensis strain 
DSM 25372, B. amyloliquefaciens strain FZB42, B. massiliosenegalensis strain JC6T, B. 
mycoides strain DSM 2048 and B. thuringiensis strain BMB171. The draft genome of B. 
massilioanorexius is larger in size than that of B. amyloliquefaciens (4.6 vs 3.9 Mb, 
respectively), similar in size than that of B. timonensis (4.6 Mb) and smaller in size than those 
of B. massiliosenegalensis, B. mycoides and B. thuringiensis (4.9, 5.5 and 5.6 Mb, 
respectively). The G+C content of B. massilioanorexius is lower than those of B. 
massiliosenegalensis, B. timonensis, B. amyloliquefaciens, B. mycoides and B. thuringiensis  
(34.10, 37.60, 37.30, 46.48, 35.21 and 35.18%, respectively). The gene content of B. 
massilioanorexius is larger than that of B. amyloliquefaciens (4,519 and 3,814, respectively) 
and fewer than those of B. massiliosenegalensis, B. timonensis, B. mycoides and B. 
thuringiensis (4,997, 4,684, 5,747 and 5,495, respectively). The ratio of genes per MB of B. 
massilioanorexius is greater than that of B. amyloliquefaciens (982 and 978, respectively), 
comparable to that of B. thuringiensis (982) and smaller to those of B. massiliosenegalensis, 
B. timonensis and B. mycoides (1,019, 1,018 and 1,044, respectively). However, the 
distribution of genes into COG categories was not entirely similar in all the three compared 
genomes (Figure 27). The nucleotide sequence identity ranged from 66.09 to 83.69% among 
Bacillus species, and from 66.09 to 70.10% between B. massilioanorexius and other Bacillus  
species, thus confirming its new species status. Table 26 summarizes the numbers of 
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orthologous genes and the average percentage of nucleotide sequence identity between the 
different genomes studied. 
Conclusion 
On the basis of phenotypic, phylogenetic and genomic analyses, we formally propose the 
creation of Bacillus massilioanorexius sp. nov. that contains the strain AP8T . The strain has 
been found in France. 
Description of Bacillus massilioanorexius sp. nov. 
Bacillus massilioanorexius (ma.si.li.o.a.no.rex’i.us. L. masc. adj. massilioanorexius, 
combination of Massilia, the Latin name of Marseille, France, where the type strain was 
isolated, and anorexia, the disease presented by the patient from whom the strain was 
cultivated). 
Colonies were 3 mm in diameter and 0.5 mm in thickness, gray in color with a coarse 
appearance on blood-enriched Columbia agar. Cells are rod-shaped with a mean diameter of 
0.77 μm. Optimal growth occurs aerobically, weak growth was observed under anaerobic 
conditions. Growth occurs between 25 and 45°C, with optimal growth observed at 37°C. Cells 
stain Gram-positive, are non-endospore forming and are motile. Cells are Gram-positive, 
catalase-positive, oxidase-positive. D-glucose, D-fructose, D-saccharose, D-trehalose, ribose, 
mannitol, mannose were used as carbon source. Positive reactions were observed for 
tryptophane deaminase, acetoin and gelatinase production. Weak reactions were obtained for 
L-rhamnose, esculine, salicine, D-cellobiose and gentiobiose. Cells are susceptible to 
amoxicillin, rifampicin, ciprofloxacin, gentamicin, doxycycline and vancomycin but resistant 
to trimethoprim/sulfamethoxazole and metronidazole. 
The G+C content of the genome is 34.10%. The 16S rRNA and genome sequences are 
deposited in GenBank under accession numbers JX101689 and CAPG00000000, respectively. 
The type strain AP8T  (= CSUR P201 = DSM 26092) was isolated from the fecal flora of a 
female suffering from anorexia nervosa in Marseille, France. 
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Table 21. Classification and general features of Bacillus massilioanorexius strain AP8T 
 MIGS ID Property Term Evidence codea 
Domain Bacteria TAS [36] 
Phylum Firmicutes TAS [37-39] 
Class Bacilli TAS [40,41] 
Domain Bacteria TAS [36] 
Current classification Order Bacillales TAS [42,43] 
Family Bacillaceae TAS [42,44] 
Genus Bacillus TAS [29,42,45] 
Species Bacillus massilioanorexius IDA 
Type strain AP8T IDA 
Gram stain Positive IDA 
Cell shape Bacilli IDA 
Motility Motile IDA 
Sporulation Nonsporulating IDA 
Temperature range Mesophile IDA 
Optimum temperature 37°C IDA 
MIGS-6.3 Salinity Unknown IDA 
MIGS-22 Oxygen requirement Aerobic IDA 
Carbon source Unknown NAS 
Energy source Unknown NAS 
MIGS-6 Habitat Human gut IDA 
MIGS-15 Biotic relationship Free living IDA 
Pathogenicity Unknown Pathogenicity 
Biosafety level 2 Biosafety level 
MIGS-14 Isolation Human feces MIGS-14 
MIGS-4 Geographic location France IDA 
MIGS-5 Sample collection time August 2011 IDA 
Latitude 43.296482 IDA 
MIGS-4.1 Longitude 5.36978 IDA 
MIGS-4.3 Depth Surface IDA 
MIGS-4.4 Altitude 0 m above sea level IDA 
Evidence codes - IDA: Inferred from Direct Assay; TAS: Traceable Author Statement (i.e., a direct 
report exists in the literature); NAS: Non-traceable Author Statement (i.e., not directly observed for 
the living, isolated sample, but based on a generally accepted property for the species, or anecdotal 
evidence). These evidence codes are from the Gene Ontology project [128]. If the evidence is IDA, 
then the property was directly observed for a live isolate by one of the authors or an expert mentioned 
in the acknowledgements. 
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Table 22. Differential characteristics of Bacillus massilioanorexius strain AP8T,  B. 
timonensis strain DSM 25372, B. amyloliquefaciens strain FZB42, B. massiliosenegalensis 
strain JC6T, B. mycoides strain DSM 2048 and B. thuringiensis strain BMB171
 Properties B. 
massilio-
anorexius 
B. 
timonensis 
B. 
amyloli-
quefaciens 
B. 
massilio-
senegalensis  
B. 
mycoides 
B.
thuringi-
ensis 
Cell diameter (μm) 0.77 0.66 0.8 0.65 1.1 1.0 
Oxygen requirement aerobic aerobic aerobic aerobic facultative 
anaerobic 
facultative 
anaerobic 
Pigment production + – – – – – 
Gram stain + – + + + + 
Salt requirement – + + + + 
Motility + + + + – 
Endospore 
formation 
– + + + + + 
Production of 
Acid phosphatase na na + w + + 
Catalase + – + + + + 
Oxidase + + + – – + 
Nitrate reductase na na + + v + 
Urease – na – – v + 
β-galactosidase na + v na + – 
N-acetyl-
glucosamine 
na + + + + + 
Acid from 
L-Arabinose – + + – + na 
Ribose + – + – + + 
Mannose + – + – + + 
Mannitol + – + – + + 
Sucrose – – + – + v 
D-glucose + – + + + + 
D-fructose + – + – + + 
D-maltose – – + + + + 
D-lactose – + + – + + 
Hydrolysis of 
Gelatin + – + – + + 
Starch na na + na + + 
G+C content (mol
%) 
34.10 37.30 46.48 37.6 35.21 35.18 
Habitat human gut human gut Soil human gut soil soil 
na = data not available; w = weak, v = variable reaction 
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Table 23. Project information 
MIGS ID Property Term 
MIGS-31 Finishing quality High-quality draft 
MIGS-28 Libraries used One 454 paired end 3-kb library 
MIGS-29 Sequencing platforms 454 GS FLX Titanium 
MIGS-31.2 Fold coverage 31.34 × 
MIGS-30 Assemblers Newbler version 2.5.3 
MIGS-32 Gene calling method Prodigal 
Genbank ID CAPG00000000 
Genbank Date of Release November 28, 2012 
Gold ID Gi20708 
MIGS-13 Project relevance Study of the human gut microbiome 
Table 24. Nucleotide content and gene count levels of the genome
 Attribute Value % of totala 
Genome size (bp) 4,616,135 
DNA coding region (bp) 3,750,534 81.24 
DNA G+C content (bp) 1,574,102 34.10 
Number of replicons 1 
Extrachromosomal elements 0
Total genes 4,519 100 
RNA genes 87 1.92 
rRNA operons 1 
Protein-coding genes 4,432 98.07 
Genes with function prediction 3,524 77.98 
Genes assigned to COGs 3,290 72.80 
Protein coding genes assigned Pfam domains 3,807 84.24 
Genes with peptide signals 270 5.97 
Genes with transmembrane helices 1,241 27.46 
CRISPR repeats 2 
a The total is based on either the size of the genome in base pairs or the total number 
of protein coding genes in the annotated genome 
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Table 25. Number of genes associated with the 25 general COG functional categories
 Code Valu
e 
%age
a 
Description 
J 171 3.86 Translation 
A 0 0 RNA processing and modification 
K 335 7.56 Transcription 
L 200 4.51 Replication, recombination and repair 
B 1 0.02 Chromatin structure and dynamics 
D 37 0.83 Cell cycle control, mitosis and meiosis 
Y 0 0 Nuclear structure 
V 76 1.71 Defense mechanisms 
T 212 4.78 Signal transduction mechanisms 
M 147 3.32 Cell wall/membrane biogenesis 
N 70 1.58 Cell motility 
Z 0 0 Cytoskeleton 
W 0 0 Extracellular structures 
U 48 1.08 Intracellular trafficking and secretion 
O 121 2.73 Posttranslational modification, protein turnover, chaperones 
C 245 5.53 Energy production and conversion 
G 221 4.99 Carbohydrate transport and metabolism 
E 405 9.14 Amino acid transport and metabolism 
F 98 2.21 Nucleotide transport and metabolism 
H 135 3.05 Coenzyme transport and metabolism 
I 136 3.07 Lipid transport and metabolism 
P 258 5.82 Inorganic ion transport and metabolism 
Q 81 1.83 Secondary metabolites biosynthesis, transport and catabolism 
R 527 11.89 General function prediction only 
S 349 7.87 Function unknown 
- 1,142 25.77 Not in COGs 
a The total is based on the total number of protein coding genes in the annotated genome. 
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Table 26. Orthologous gene comparison and average nucleotide identity of Bacillus species 
B. massilioanorexius1 with B. massiliosenegalensis2; B. timonensis3, B. thuringiensis4; B. 
mycoides5; B. amyloliquefaciens6†. 
B. 
massilio-
anorexius 
B. 
massilios-
enegalensis 
B.  
timonensis 
B.  
thuringiensis 
B.  
mycoides  
B. 
amyloliquefaciens 
B. massilioanorexius 4,432 1,897 1,864 1,887 1,794 1,709 
B.massiliosenegalensis 70.10 4,895 1,965 1,863 1,765 1,755 
B. timonensis 69.84 70.33 4,610 1,864 1,762 1,742 
B. thuringiensis 69.35 68.88 69.31 6,243 2,210 1,832 
B. mycoides 69.41 69.11 69.41 83.69 5,885 1,719 
B. amyloliquefaciens 66.09 67.02 67.12 66.35 66.57 3,823 
†Upper right, numbers of orthologous genes; lower left, mean nucleotide identities of  
orthologous genes. Bold numbers indicate the numbers of genes or each genome. 
1Genbank accession number CAPG00000000, 2CAHJ00000000, 3CAET00000000,  
4CP001903, 5CM000742, 6NC_009725 
Figure 21. Phylogenetic tree highlighting the position of Bacillus massilioanorexius strain 
AP8T relative to a selection of type strains of validly published species of Bacillus genus. 
GenBank accession numbers are indicated in parentheses. Sequences were aligned using 
CLUSTALW, and phylogenetic inferences obtained using the maximum-likelihood method 
within MEGA program. Numbers at the nodes are percentages of bootstrap values obtained by 
repeating the analysis 500 times to generate a majority consensus tree. Clostridium botulinum 
was used as outgroup. The scale bar represents a 2% nucleotide sequence divergence. 
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Figure 22. Gram staining of B. massilioanorexius strain AP8T 
Figure 23. Transmission electron microscopy of B. massilioanorexius strain AP8T, using a 
Morgani 268D (Philips) at an operating voltage of 60kV. The scale bar represents 1µm. 
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Figure 24. Reference mass spectrum from B. massilioanorexius strain AP8T. Spectra from 12 
individual colonies were compared and a reference spectrum was generated. 
Figure 25. Gel view comparing B. massilioanorexius sp. nov strain AP8T and other Bacillus  
species. The gel view displays the raw spectra of loaded spectrum files arranged in a pseudo-
gel like look. The x-axis records the m/z value. The left y-axis displays the running spectrum 
number originating from subsequent spectra loading. The peak intensity is expressed by a 
Gray scale scheme code. The color bar and the right y-axis indicate the relation between the 
color a peak is displayed with and the peak intensity in arbitrary units. Displayed species are 
indicated on the left. 
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Figure 26. Graphical circular map of the chromosome. From the outside in, the outer two 
circles show open reading frames oriented in the forward and reverse directions (colored by 
COG categories), respectively. The third circle shows the rRNA gene operon (red) and tRNA 
genes (green). The fourth circle shows the G+C% content plot. The inner-most circle shows 
GC skew, purple and olive indicating negative and positive values, respectively. 
Figure 27. Distribution of functional classes of predicted genes in B. massilioanorexius (red), 
B. massiliosenegalensis (blue), B. timonensis (pink), B. amyloliquefaciens (yellow), B. 
mycoides (brown) and B. thuringiensis (green) chromosomes according to the clusters of 
orthologous groups of proteins. 
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2.3. Description of further bacteria isolated for the first time in this 
work
In the following, the 10 further newly discovered bacteria will be described. In contrast to the 
previous article on Bacillus massilioanorexius only results generated by my own work will be 
stated. The most important phenotypical characters and growth conditions will be described in 
detail. Except oxidase and catalase activity it will be passed on listing biochemical 
characterization. Phylogenetic trees of all newly discovered bacterial species can be found in 
figure S1 in chapter 2.1.1 and are not displayed here.
2.3.1 Alistipes ihumii
(The name has been changed from „Alistipes marseilloanorexicus“ used in „Culturomics 
identified 11 new bacterial species from a single anorexia nervosa stool sample“ to current 
and definitive name „Alistipes ihumii“)
Alistipes ihumii AP11T belongs to the phylum of Bacteroidetes and has been isolated from 
Columbia-Agar in anaerobic atmosphere after preincubation in anaerobic blood culture with 
addition of Thioglycolate. Colonies of A. ihumii AP11T  appeared transparent on Columbia-
Agar, with a diameter of 0,2 mm, grew very close to each other and showed ß-hemolysis. 
Optimal growth occurred in anaerobic conditions, only weakly in microaerophilic and not in 
aerobic conditions or with 5% CO2. Colonies grew between 25-45°C, with optimal growth at 
37°C. Cells are non-motile rods with a mean diameter of 0.72 µm. They are gram-negative 
and have a  negative catalase and positive oxidase activity.
Fig. 31. Electron microscopy of Alistipes ihumii AP11T. Scale bar: 500 nm.
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2.3.2 Bacteroides timonensis
Bacteroides timonensis AP1T belongs to the phylum of Bacteroidetes. The sample has been 
incubated for 1 month on Columbia-Agar in anaerobic atmosphere. Colonies of B. timonensis  
AP1T appeared transparent on Columbia-Agar with a creamy solid consistence and a diameter 
of 0,33 mm. They grew on each other, creating smears with thickness upon 0,5 mm. Optimal 
growth occurred in anaerobic and microaerophilic conditions, only weakly under 5% CO2 and 
not in aerobic conditions. Colonies grew between 25-37°C, with optimal growth at 37°C. 
Cells are non-motile rods with a mean diameter of 0.88 µm. They are gram-negative and have 
a positive catalase and negative oxidase activity. B. timonensis AP1T  is susceptible to 
doxycycline, amoxicillin + clavulanic acid, metronidazole, imipenem, weakly to vancomycin 
and is resistant to penicillin G.
Fig. 32. Electron microscopy of Bacteroides timonensis AP1T. Scale bar: 200 nm. 
2.3.3 Blastococcus massiliensis
Blastococcus massiliensis AP4T belongs to the phylum of Actinobacteria and has been 
isolated on Brucella-Agar in aerobic atmosphere. Colonies of B. massiliensis AP4T appeared 
opaque whitely on Columbia-Agar, had a creamy consistence and a diameter of 0,5 mm. 
Growth occurred in aerobic, microaerophilic conditions and under 5% CO2, very weakly after 
2 days in anaerobic conditions. Colonies grew between 25-37°C, after 2 days very weakly at 
45°C, with optimal growth at 37°C. Cells are non-motile elongate cocci with a mean diameter 
of 0.4 µm. They are gram-positive and have a positive catalase and negative oxidase activity. 
B. massiliensis AP4T  is susceptible to vancomycin, imipenem, amoxicillin + clavulanic acid, 
51
doxycycline, penicillin and resistant to metronidazole.
Abb. 33. Electron microscopy of Blastococcus massiliensis AP4T. Scale bar: 300nm.
2.3.4 Clostridium ihumii 
(The name has been changed from „Clostridium anorexicus“ used in „Culturomics identified 
11 new bacterial species from a single anorexia nervosa stool sample“ to current and 
definitive name „Clostridium ihumii“)
Fig. 34. Electron microscopy of Clostridium ihumii AP6T. Scale bar: 900nm.
Clostridium ihumii AP6T belongs to the phylum of Firmicutes. The sample has been incubated 
on Columbia-Agar in anaerobic atmosphere after preincubation in anaerobic blood culture 
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with addition of sheep blood. Colonies of C. ihumii AP6T appeared whitely on Columbia-
Agar, with a diameter of 0,5 mm and grew in large distance to each other. Growth only 
occurred in anaerobic conditions. Colonies grew between 25-45°C, with an optimal growth at 
37°C. Cells are non-motile rods with a mean diameter of 0.69 µm. They are gram-positive and 
have a negative catalase and a positive oxidase activity.  
2.3.5 Clostridium anorexicamassiliense
Clostridium anorexicamassiliense AP5T belongs to the phylum of Firmicutes. The sample has 
been incubated on Columbia-Agar in anaerobic atmosphere after preincubation in anaerobic 
blood culture with addition of sheep blood. Colonies of C. anorexicamassiliense AP5T had a 
irregular appearance on Columbia-Agar, were blue-green to gray, opaque with a displeasing 
smell and had a diameter of 5 mm. Growth only occurred in anaerobic condition. Colonies 
grew between 25-45°C, with optimal growth at 37°C. Cells are non-motile rods with very 
variegate diameter. They are gram-positive and have a positive catalase and negative oxidase 
activity. 
Fig. 35. Electron microscopy of Clostridium anorexicamassiliense AP5T. Scale bar: 500nm.
2.3.6 Dorea massiliensis
Dorea massiliensis AP3T belongs to the phylum of Firmicutes. The sample has been incubated 
on Columbia-Agar in anaerobic atmosphere after preincubation in anaerobic blood culture 
with addition of rumen of a sheep. Colonies of  D. massiliensis AP3T appeared light brown on 
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Columbia-Agar and were very small and  plane. Growth occurred in anaerobic, 
microaerophilic, aerobic condition with and without 5% CO2.  Colonies grew between 25-
45°C, with optimal growth at 37°C. Cells are non-motile gram-positive rods.
Abb. 36. Electron microscopy of  Dorea massiliensis AP3T. Sale bar: 500nm.
2.3.7 Holdemania massiliensis
Holdemania massiliensis  AP2T  belongs to the phylum of Bacteroidetes. The sample has been 
incubated on Columbia-Agar in anaerobic atmosphere after preincubation in anaerobic blood 
culture with addition of Thioglycolate. Colonies of H. massiliensis AP2T appeared light gray 
on Columbia-Agar, had a creamy consistence, a diameter of 0,2 mm and showed ß-hemolysis. 
Growth only occurred in anaerobic atmosphere. Colonies grew after 72 hours between 25-
30°C, with optimal growth after 24 hours at  37°C. Cells are non-motile rods with a mean 
diameter of 0.57 µm. They are gram-positive and have a  negative catalase and positive 
oxidase activity.
Abb. 37. Electron microscopy of  Holdemania massiliensis AP2T . Scale bar: 900nm.
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2.3.8 Streptomyces massiliensis 
Streptomyces massiliensis AP7T belongs to the phylum of Actinobacteria. The sample had 
been diluted and filtrated through 0,45 µm and incubated on BHI-Agar in aerobic condition. 
Colonies of S. massiliensis AP7T appeared greenly gray on Columbia-Agar, had a diameter of 
0,4 mm and were very dry and adhesive. Optimal growth occurred in aerobic conditions, 
weakly under 5% CO2  and not in anaerobic or microaerophilic atmospheres. Colonies grew 
between 30-45°C, with optimal growth at 37°C-45°C. Cells are non-motile linear rods with a 
mean diameter of 0.54µm. They are gram-positive and have a positive catalase and oxidase 
activity.
Abb. 38.1. Electron microscopy of  Streptomyces massiliensis  AP7T . Scale bar: 2µm.
Abb. 38.2. Gram-straining of Streptomyces massiliensis  AP7T
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2.3.9 Soleaferrea massiliensis 
Soleaferrea massiliensis AP10T  belongs to the phylum of Firmicutes and to the family of 
Ruminococcaceae. It is a new genus. The sample has been incubated on Columbia-Agar in 
anaerobic atmosphere after preincubation in anaerobic blood culture with addition of 
Thioglycolate. Colonies of Soleaferrea massiliensis AP10T appeared gray on Columbia-Agar, 
had a rough surface, a diameter of upon 3 mm and a thickness of 0,5mm. Optimal growth 
occurred in anaerobic but also in aerobic condition with or without CO2. Colonies grew 
between 35-45°C, with optimal growth at 37°C. Cells are non-motile curved rods with a mean 
diameter of 0.64µm. They are gram-positive and have a negative catalase and positive oxidase 
activity.
Abb. 39.1. Electron microscopy of  Soleaferrea massiliensis AP10T. Scale bar: 1µm.
Abb. 39.2. Gram-straining of Soleaferrea massiliensis AP10T
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2.3.10 Stoquefichus massiliensis 
Stoquefichus massiliensis AP9T belongs to the phylum of Firmicutes and to the family of 
Erysipelotrichaceae. The new genus has been isolated after anaerobic incubation at 28°C on 
Columbia-Agar. 
Colonies of Stoquefichus massiliensis AP9T appeared silver on Columbia-Agar, with a 
diameter of 0,5 mm and grew close to each other thus forming either a carpet of small 
colonies, or 1 mm thick drops of irregular colonies. Optimal growth occurred in anaerobic 
condition, only weakly in microaerophilic and not in aerobic conditions with or without 5% 
CO2. Colonies grew between 25-45°C, with optimal growth at 37°C. Cells are non-motile 
rods with a mean diameter of 0.62 µm. They are gram-positive and have a positive catalase 
and oxidase activity.
Abb. 30. Electron microscopy of  Stoquefichus massiliensis AP9T. Scale bar: 500nm. 
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3. Discussion
In this study, the intestinal microbiota of an anorexia nervosa patient has been examined for 
the first time.
The identification of the cultivated bacteria was worked out either by mass spectrometry or by 
sequencing of 16S rRNA. Mass spectrometry is a validated, time effective method for 
identification of bacteria in clinical laboratories of microbiology [129][130] and the gene 
sequence 16S rRNA is the standard for sequencing bacterial genes [84]. Therefore the results 
of this study have been supported with validated methods. 
Anorexia nervosa
As this study examines a single sample of one person, no conclusions can be made on 
correlations between bacterial species and development of disease. The patient regrettably 
died due to her illness. A longitudinal study which could have observed transformation and 
adaption of intestinal flora to an eventual change of diet or treatment becomes thereby 
impossible. But the obtained results of this study on the intestinal microflora of an anorexia 
patient can be compared to other data as presented in introduction. 
Firstly there are the studies on gut flora of undernourished children. The restrictive diet of an 
anorexia patient differs naturally from classical undernourishment: the food of our patient was 
in fact quantitatively poor but she had payed attention to ingest all necessary nutrients and 
vitamins. Nevertheless in both forms in total a shortage of nutrients is dominating. This 
shortage affects the intestinal mucosa and the gut flora probably adapts to the negative energy 
balance. The resulted data of the sample of the anorexia patient features analogies to the gut 
flora of undernourished children. This concerns over all a group of bacteria which do either 
have anti-inflammatory or inflammatory effects: Bilophila wadsworthia (correlating with 
inflammatory bowel diseases) and Clostridium innocuum (in relation with opportunistic 
infections) can be found as well in undernourished children [45] as well as in our patient. 
Anti-inflammatory bacteria such as Eubacterium, Phascolarctobacterium, Roseburia and 
Faecalibacterium were in contrast only missing in undernourrished children [43]. In addition 
to the pathogen species Haemophilus parainfluenzae found in both forms, Porphyromonas 
somerae has been detected in the sample of the Anorexie nervosa patient. Interestingly this 
bacterial group has been only found in stool samples of patients with  M. Crohn until now 
[131]. 
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It could be examined in future studies whether restrictive diet of  anorexia nervosa also results 
in increased intestinal inflammatory activity as it seems to be the case in undernourishment 
due to poverty. 
Secondly there is the approach to explain the development of anorexia nervosa by 
immunological processes, as described in introduction. This approach postulates a stimulation 
of antibodies by molecular mimicry with intestinal bacteria. 
The first neuropeptide which seems to play a role in this context is α-MSH. Bacteria with 
influence on this molecule are Bifidobacterium longum, Bacteroides, Bacillus cereus and 
Escherichia coli [34]. All these bacteria have been isolated in this study. Apart from that there 
is Enterobacteria phage and the fungal species Yarrowia lipolytica, Candida albicans,  
Cryptococcus neoformans and Aspergillus fumigatus [34]. On viruses and fungi this study can 
not make a statement.
Antibodies against Ghrelin are expected to be reduced in anorexia patients [41] and can also 
be stimulated by certain bacteria. The bacteria known to influence this stimualation, 
Enterococcus faecalis and Cl. Perfringens [34], have been isolated from the sample of our 
patient. Again an other study has to be made for the virus Lactobacillus casei bacteriophage 
and for the eukaryotes  Mycobacteriophage, Saccharomyces cerevisiae, Yarrowia lipolytica,  
Candida albicans and Cryptococcus neoformans [34].
Finally only one bacterial species has been found in this study which stimulates the 
production of antibodies against the „satiety hormone“ Leptin: Lactococcus lactis [34]. Apart 
from Lactobacillus bacteriophage and the fungi (Candida albicans, Yarrowia lipolytica and 
Aspergillus fumigatus) there are also bacteria missing in our study for the stimulation of 
antibodies against Leptin: H. pylori and Campylobacter [33].
Lactococcus lactis has been identified with 13 reads in metagenomics. L. lactis is thereby one 
of the bacteria of this sample only appearing in a small concentration. Also in culturing L. 
lactis has been isolated comparatively rarely. It could be supposed that in the patient of our 
study only few bacteria stimulate the production of antibodies against Leptin through 
molecular mimicry and that in consequence free Leptin is increased in plasma and gives a 
feeling of satiety to the patient. But this is contradicting results of previous studies where 
Leptin is found to be reduced in anorexia patients [132]. For the moment it is impossible to 
state effects of bacteria on the regulation of food intake, or to directly conclude the 
concentration of neuropeptides from the number of bacteria which have an influence on these 
respective neuropeptides. It still has to be researched how in detail the mechanism works to 
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change the balance of respective hormones in anorexia patients compared to healthy persons 
through stimulation of antibodies by intestinal bacteria. For this aim more microbiota of 
anorexia patients could be examined in future and be compared to microbiota of healthy 
subjects concerning the bacteria with influence on neuropeptides listed above. 
In this study it is certain that the microflora of the anorexia patient possesses bacteria which 
can make molecular mimicry with all of the neuropeptides known until now to have an effect 
on hunger and food intake.  
If the influence of the microbiome - and antibodies against neuropeptides regulating food 
intake- on the development of anorexia nervosa will be confirmed, it would have an important 
impact. On one hand it would change the image of a disease which has been classified to be 
purely psychological until now. This would influence the interaction with these patients and of 
course the therapy. To heal anorexia nervosa by modifying the intestinal microbiota seems to 
be scientifically unrealistic up to date. But there might be a possibility to bring hormones 
regulating food intake back into a natural balance and by this process influence positively the 
organic component of the disease. 
All bacteria which have an effect on neuropeptides have been cultivated. But two of them 
have not been identified by metagenomics. These are Bacillus cereus and Enterococcus 
faecalis. In future metagenomic studies on microbiota of anorexia nervosa patients this should 
be considered and these bacteria should be researched separately because they might play an 
important role in this disease. 
This leads to the next point: the relevance of culturing.
Culturomics and newly discovered species
This study affirms the benefit of cultivation to complete metagenomic results.  
109 species have been isolated by culture which have not been identified by metagenomics. 
This constitutes with 65% a large part of all identified bacteria in this sample. Only 23 species 
have been detected by both methods. This accounts only 17% of all cultivated bacteria. In this 
study cultivation contributed more than metagenomics to explore the bacterial diversity. If one 
sample is examined by only one of these techniques, with the current existing possibilities a 
complete view on the bacterial diversity will not be obtained. 
Why did 109 cultivated bacteria could not be detected by metagenomics? 
Apparently some genes could not be assigned although their respective bacteria have been 
described and their reference genes added to the database before. This could be caused by too 
short reads or other technical limits of metagenomics [55]. The metagenomic study has been 
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performed in 2010/11. Since this a lot of advancements have been made in metagenomics 
[133] and it can be assumed that metagenomics today would detect more bacteria in the same 
sample. The number of not detected gene sequences should therefore continue falling in 
future.
One part of those bacteria which were not detected by metagenomics probably occurred in a 
too small concentration. This challenge will remain [134]. Here, with selective growth 
inhibition, culturing can detect some species which can not be identified by metagenomics. 
The question is if these bacteria occurring in a low concentration play an important role in the 
microbiome. But if this is the case, cultivation stays indispensable as long as metagenomics 
has not developed better techniques. 
The time effort to complete each examination of micobiota by a culturing of the sample is 
regrettably too high to be made in parallel in each study. To discover correlations between 
certain bacterial populations and diseases or other characteristics, studies have to be mainly 
supported by metagenomics. Nevertheless metagenomic results should currently be regularly 
controlled and completed by culturing. 
The newly identified 9 bacterial species and 2 bacterial genera which have been isolated from 
this sample continue giving value to cultivation. Their genome sequences have been published 
and are now accessible to metagenomic studies. 
Which significance does cultivation have in the discovery of new bacterial species? From 
genes gained without cultivation, encoded enzymes and other proteins can be deduced. The 
genome of one bacteria contains per definition all information. However natural products of 
bacteria can only be gained after cultivating the bacterium itself [53]. These products are for 
instance the base of antibiotics. Medicine needs new antibiotics, because more and more 
bacteria are getting resistant to the common products [54]. This aspect demonstrates the 
opportunities included in cultivation of new species. Also the „behavior“ of bacteria and the 
signal transmission in vivo can only be described by cultivation [53]. A bacterium which is 
only registered by metagenomics and described by its genome, is not completely explored and 
it is at this point that cultivation becomes indispensable.
Compared to the estimated number of yet unknown bacteria, the count 11 is vanishing small. 
But only the bacteria newly discovered in the last 5 years in the Culturomics-project counted 
together constitute 75% of all newly described bacteria in this time [135]. This way, the study 
has reached its aim to explore the bacterial diversity in general and especially in human gut 
flora, and contributes to the expansion of its repertoire. 
Moreover 8 known bacteria have been added to the Human Gut Repertoire which were 
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isolated from human gut for the first time in this study. 
A part of the newly described bacteria from other stool samples of this project were also 
isolated in this study. Therefore it can be suspected that these newly discovered bacteria are 
part of the Human Gut Repertoire which also occurs in other individuals. For the study of 
anorexia  it will be interesting whether the newly discovered bacterial species in this sample 
will be found increased in other samples of persons with eating disorders or 
undernourishment. 
In the sense of the project it can be continued to explore samples from persons with different 
influencing factors on the intestinal flora, such as geography, special dietary habits like the 
patient in this study, and intake of medicaments, especially antibiotics. On the strength of past 
experience there is an important potential to isolate further intestinal bacteria and new species. 
Challenges
How can we reach cultivation of bacteria which have only been detected by metagenomics so 
far? Most of these species in our study (28 out of 36, 77,8%) are anaerobic. The strict 
anaerobic conditions can be in fact improved. Anaerobic cultures in this study have indeed 
been incubated in anaerobic jars with respective atmosphere generators, but inoculation on 
agar was carried out in normal atmosphere containing oxygen. Also the first steps meaning 
transport, partition into aliquots and the freezing of the sample have been conducted without 
any special adherence to anaerobic atmosphere. In future one part of the sample could be 
treated anaerobically as soon as obtained to avoid destruction of strictly anaerobic bacteria. 
Also further steps of dilution and inoculation could be made in optimized, anaerobic 
conditions.  
Aerobic or facultative anaerobic bacteria of this sample, which could not be cultivated are 
following: Enterococcus saccharolyticus, Brevibacterium massiliense, Streptococcus mutans, 
Rothia mucilaginosa, Serratia ficalia, Pelomonas saccharophila, Lactococcus raffinolactis,  
and Lactobacillus rogosae. 
The first four species do not have any special characteristics which could explain why they 
were not detected by culture. These bacteria have been probably destroyed while preparation, 
did not grow on the used culture medium or their colonies have been missed while isolating. 
But then it is noticeable that Serratia ficalia, Lactococcus raffinolactis and Pelomonas 
saccharophila have been isolated only out of food or water until now and need special culture 
conditions which have not been applied in this study [136][137]. Particularly they all grow at 
temperatures not exceeding 30°C. By broadening the diversity of culture conditions, the gap 
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in culturing could be continued to be reduced. Finally Lactobacillus rogosae seems to be a 
bacterial species which does not exist in any collection of microorganisms [138] and which is 
therefore either not cultivable or not valid. L. rogosae should be examined more in detail to 
develop adapted conditions for its cultivation. In further studies of the Culturomics project, 
more cultures could be incubated with temperatures between 25°- 30°C and more special 
culture media such as R2A-Agar could be used [137].
All listed uncultured bacteria were detected in metagenomics with only few reads (at the most 
7, mostly with only one read). This means that they occur in a small concentration. This 
increases the risk in culture to be dominated by other species and not to be isolated by the 
searcher. This can also explain why they have not been found in cultivation.
But many other bacteria with only one read in metagenomics were isolated nevertheless and 
partly even in simple culture conditions. One aim of this research work was to suppress some 
of the bacterial populations to enable others to grow. For this special culture media, addition 
of antibiotics, filtration and other conditions have been applied. Within these culture 
conditions there was no one which was especially advantageous. It is rather the multitude of 
different conditions which makes the large diversity of cultivated bacteria and characterizes 
the Culturomics project and its study presented here.  
Finally there is the unknown part of microorganisms which becomes visible in metagenomic 
studies but cannot be identified and characterized. Almost 5% of gene sequences obtained in 
this study could not be classified. Beside technical limits this could present an indication of 
unknown bacteria which have to be discovered in future.  
The presented research work, as a part of the Culturomics project, contributed to the 
exploration of the inter-individual as well as the individual diversity of intestinal microbiota. 
The present study provides a high number of identified species, including 11 newly described 
bacteria. Exploring the diversity of gut flora also contributes to make the large field of 
unknown bacteria more accessible. 
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4. Summary
1014 bacteria live in the human intestine. The composition of the gut flora differs from 
individual to individual and is dependent on multiple factors. Bacteria can play important 
roles in processes concerning our whole body. As the development of disease can also be 
explained by this approach, the intestinal microbiota is currently intensively explored. 
The presented study is part of a project exploring the diversity of the human gut flora. In this 
context a stool sample of a 21 year old anorexia nervosa patient has been examined on the 
contained bacteria. For this aim 88 different culture conditions have been applied to enable 
growth of the most possible different species. Multiple established and new developed culture 
media have been inoculated and atmosphere, temperature and time of incubation has been 
varied. In addition active and passive filtration, phages and blood culture bottles with or 
without addition of nutriments have been applied.
In parallel the same sample has been examined by colleagues using pyrosequencing.
133 species have been isolated, belonging to the phyla Firmicutes, Actinobacteria,  
Bacteroidetes and Proteobacteria. 19 bacteria have been isolated from human intestine for the 
first time. Out of these 19, 11 species have been newly discovered and described in this study. 
These are 2 new genera  Stoquefichus massiliensis and Soleaferrea massiliensis and 9 new 
species Dorea massiliensis, Clostridium ihumii, Clostridium anorexicamassiliense,  
Holdemania massiliensis, Bacillus marseilloanorexius, Alistipes ihumii, Bacteroides 
timonensis, Streptomyces massiliensis and Blastococcus massiliensis. 
The new bacteria have been described by me and their genomes sequenced  by colleagues. In 
consequence more genes should be assigned successfully in future metagenomic studies.  
Between the results of culturing and metagenomics there is only a small overlap. Only 17% of 
the cultivated bacteria have been also identified by metagenomics. On the other hand 
metagenomics detected 36 species which could not be cultivated in this study.  
The intestinal microbiota of the anorexia nervosa patient possesses bacteria which can 
stimulate the production of certain antibodies by molecular mimicry with antigens. These 
antibodies influence the balance of hormones which regulate food intake and could play a role 
in the development of anorexia nervosa. Parallels to the intestinal flora of undernourished 
children concern overall bacteria with influence on inflammation. Eventually some of the 
newly discovered bacteria also have a relation with anorexia nervosa.
As this study is made on a single sample of one patient, we need more studies on the 
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constitution of the intestinal flora of anorexia nervosa patients for concluding correlations 
between microflora and disease. This work provides first data. 
The study also compares culturing and metagenomics. The results show that with current 
methods a complete view on the intestinal flora can only be obtained by combining both 
methods. 
The present research contributes to an extended description of human intestinal microflora 
and led to the discovery of 11 new bacteria.  
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Deutsche Zusammenfassung
Im menschlichen Darm leben 1014 Bakterien. Die Zusammensetzung der Darmflora ist von 
Mensch zu Mensch unterschiedlich und von verschiedenen Faktoren abhängig. Bei Vorgängen 
in unserem gesamten Körper spielen die Bakterien eine zum Teil wichtige Rolle. Da damit 
auch die Entstehung vieler Krankheiten erklärt werden kann, wird die intestinale Mikrobiota 
zur Zeit intensiv erforscht.  
Die hier vorgestellte Studie ist Teil eines Projektes zur Erforschung der Diversität der 
menschlichen Darmflora. In diesem Sinne wurde die Stuhlprobe einer 21-jährigen Anorexia 
Patientin auf die darin enthaltenen Bakterien untersucht. Dazu wurden 88 verschiedene 
Kulturkonditionen angewandt um möglichst vielen Arten das Wachstum zu ermöglichen. 
Verschiedene bekannte und neu entwickelte Nährböden wurden beimpft und Atmosphäre, 
Temperatur und Inkubationszeit variiert. Außerdem wurde aktive und passive Filtration 
angewandt, Phagen benutzt, in Blutkulturflaschen mit oder ohne Beimengung von 
Verdauungssäften oder sterilem Stuhl präinkubiert  und schließlich neu entwickelte 
Nährböden mit Banane, Camembert oder Joghurt in Anlehnung an die 
Ernährungsgewohnheiten der Patientin angewandt. Die Kolonien wurden per MALDI-TOF 
identifiziert oder die DNA der Bakterien extrahiert, das 16s rRNA-Gen amplifiziert, 
sequenziert  und mit BLAST mit der Datenbank abgeglichen. Bei einer Similarität <98.7 % zu 
bekannten Spezien wurde eine neue Spezies vermutet und die Bakterien weiter biochemisch, 
physikalisch und phänotypisch analysiert. 
Parallel dazu wurde die selbe Probe von Kollegen per Pyrosequencing untersucht. 
Es wurden 133 Spezies isoliert, die den Phyla Firmicutes, Actinobacteria, Bacteroidetes und 
Proteobacteria angehören. 19 der Bakterien wurden zum ersten Mal aus dem menschlichen 
Darm isoliert. Von diesen wiederum sind 11 Bakterien von mir neu entdeckt und beschrieben 
worden. Es handelt sich um die 2 neuen Gattungen  Stoquefichus massiliensis und Soleaferrea 
massiliensis und die 9 neuen Spezies Dorea massiliensis, Clostridium ihumii, Clostridium 
anorexicamassiliense, Holdemania massiliensis, Bacillus marseilloanorexius, Alistipes 
ihumii, Bacteroides timonensis, Streptomyces massiliensis und Blastococcus massiliensis. 8 
dieser neuen Bakterien sind anaerob, 7 wurden nach Präinkubation in Blutkulturflaschen 
entdeckt, 2 davon bei Zugabe von Verdauungssäften.
Die neuen Bakterien wurden beschrieben und deren Genome von Kollegen sequenziert. 
Damit können in Zukunft mehr Gene in metagenomischen Studien erfolgreich zugeordnet 
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werden. 
Mit den Ergebnissen der metagenomischen Untersuchung zeigt sich eine nur geringe 
Überlappung. Nur 17% der kultivierten Bakterien wurden auch in der Metagenomik 
identifiziert, die ihrerseits 36 Spezies erfasste, die nicht kultiviert werden konnten. 
Die intestinale Mikrobiota der Anorexia Patientin enthält Bakterien, die durch Molekulares 
Mimikry mit Antigenen die Produktion von bestimmten Antikörpern stimulieren. Diese 
Antikörper beeinflussen das Gleichgewicht von Hormonen, die die Nahrungsaufnahme 
regulieren und in der Krankheitsentstehung von Anorexia nervosa eine Rolle spielen könnten. 
Parallelen zur Darmflora von unterernährten Kindern zeigen sich vor allem bei bestimmten 
Bakterienarten mit Einfluss auf Entzündung. Eventuell stehen auch manche der neu 
entdeckten Bakterien im Zusammenhang mit Anorexia nervosa.
Da es sich um eine einzelne Probe einer einzigen Patientin handelt, braucht man weitere 
Studien über die Zusammensetzung der Darmflora von Anorexia Patienten, um Aussagen über 
einen Zusammenhang zwischen Mikrobiota und Krankheit machen zu können. Diese Arbeit 
liefert hierfür erste Daten.
Die Studie vergleicht außerdem Kultivierung mit Metagenomik. Die Ergebnisse zeigen, dass 
man beim aktuellen Stand der Wissenschaft nur dann ein vollständiges Bild der Darmflora 
erhalten kann, wenn beide Methoden kombiniert werden. 
Die vorliegende Forschungsarbeit trägt zu einer erweiterten Beschreibung der menschlichen 
Darmflora bei und führte zur Entdeckung von 11 bisher unbekannten Bakterien.
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